<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v3.0 20080202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing3.dtd?><?SourceDTD.Version 3.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">F1000Prime Rep</journal-id><journal-id journal-id-type="iso-abbrev">F1000Prime Rep</journal-id><journal-title-group><journal-title>F1000Prime Reports</journal-title></journal-title-group><issn pub-type="epub">2051-7599</issn><publisher><publisher-name>Faculty of 1000 Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">4126534</article-id><article-id pub-id-type="doi">10.12703/P6-69</article-id><article-id pub-id-type="publisher-id">69</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>Pathogenesis of idiopathic pulmonary fibrosis: review of recent findings</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Renzoni</surname><given-names>Elisabetta</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><email xlink:href="mailto:e.renzoni@imperial.ac.uk">e.renzoni@imperial.ac.uk</email><ext-link ext-link-type="uri" xlink:href="http://f1000.com/prime/thefaculty/member/1998511657250735"/></contrib><contrib contrib-type="author"><name><surname>Srihari</surname><given-names>Veeraraghavan</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Sestini</surname><given-names>Piersante</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><aff id="aff1"><label>1</label><institution>Interstitial Lung Disease Unit, Royal Brompton Hospital and National Heart and Lung Institute</institution><addr-line>Imperial College London, Emmanuel Kaye Building, 1B Manresa Road, London SW3 6LR</addr-line><country>UK</country></aff><aff id="aff2"><label>2</label><institution>Department of Medicine, Division of Pulmonary, Allergy and Critical Care, Emory University</institution><addr-line>1365 Clifton Rd NE Rm A 4319, Atlanta, GA 30322</addr-line><country>USA</country></aff><aff id="aff3"><label>3</label><institution>Respiratory Medicine Department, Ospedale &#8220;Le Scotte&#8221;, University of Siena, viale Bracci</institution><addr-line>53100 Siena</addr-line><country>Italy</country></aff></contrib-group><pub-date pub-type="epub"><day>01</day><month>8</month><year>2014</year></pub-date><pub-date pub-type="collection"><year>2014</year></pub-date><volume>6</volume><elocation-id>69</elocation-id><permissions><copyright-statement>&#169; 2014 Faculty of 1000 Ltd</copyright-statement><copyright-year>2014</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/legalcode"><license-p>All F1000Prime Reports articles are distributed under the terms of the Creative Commons Attribution-Non Commercial License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>Idiopathic pulmonary fibrosis (IPF) is likely to result from the interaction between environmental exposures, including cigarette smoke, and genetic predisposition. This review focuses on clues provided by recent genetic association studies and other selected data and hypotheses. In IPF, association with surfactant mutations has highlighted the importance of type II epithelial cells, while shortened telomeres in some patients suggest that accelerated aging may play a role in the pathogenesis of lung fibrosis, possibly by affecting the renewal/differentiation potential of epithelial cells. The finding that a common variant in mucin 5B predisposes individuals to both familial and sporadic IPF suggests a hitherto under-investigated role of bronchiolar cells and mucins. Although the pathogenetic link between mucins and lung fibrosis is not known, it is possible that MUC5B overexpression interferes with physiological mucosal host defense, with reduced clearance of micro-organisms or inorganic noxious agents, or induction of endoplasmic reticulum stress. Other components of innate and adaptive immunity are likely to be involved in IPF pathogenesis/progression. Finally, the importance of the clotting cascade in IPF pathogenesis has been confirmed by a recent epidemiological study, in which patients with IPF were almost five times more likely than general population controls to have at least one inherited or acquired clotting defect.</p></abstract></article-meta><notes><p>The electronic version of this article is the complete one and can be found at: <ext-link ext-link-type="uri" xlink:href="http://f1000.com/prime/reports/m/6/69">http://f1000.com/prime/reports/m/6/69</ext-link></p></notes></front><body><sec sec-type="intro" id="s01"><title>Introduction</title><p>Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic disease limited to the lungs, occurring in older individuals, more frequently men, and characterized by a dismal prognosis, with a median survival of 3 to 5 years since diagnosis, although a wide variability in disease course is increasingly recognized. According to the more commonly held and current pathogenetic model, IPF results from recurrent injury to epithelial cells caused by a variety of exposures. These include cigarette smoke, dusts, and other environmental agents, which, in a genetically predisposed individual, lead to activation of abnormal pathways, resulting in failed resolution of the wound-healing response. This article does not aim to provide an exhaustive review of pathogenetic pathways in IPF, but rather will focus on selected topics, in particular on contributions to the understanding of IPF pathogenesis provided by recent genetic association studies, and other selected data and hypotheses.</p></sec><sec id="s02"><title>Genetic studies</title><p>Genetic predisposition to IPF is supported by familial clustering, the occurrence of lung fibrosis in genetic multi-system disorders, and differing susceptibilities in humans exposed to similar levels of fibrogenic agents. Genetic association studies are useful in identifying relevant molecules/cell types among the wide array of potential pathogenetic pathways and can highlight otherwise unexpected areas.</p><sec id="s02_1"><title>The role of type II cells</title><p>Mutations in the genes for surfactant protein C (<italic>SFTPC</italic>) and surfactant protein A2 (<italic>SFTPA2</italic>) have been described in association with familial lung fibrosis [<xref rid="bib-001" ref-type="bibr">1</xref>,<xref rid="bib-002" ref-type="bibr">2</xref>] and rarely with sporadic IPF [<xref rid="bib-003" ref-type="bibr">3</xref>,<xref rid="bib-004" ref-type="bibr">4</xref>]. Although they account for only approximately 1% of familial cases, the fact that both surfactant proteins are exclusively synthesized by type II alveolar epithelial cells points to type II cell dysfunction as a key element in IPF. The relevance of type II cells is also suggested by the prognostic value of serum surfactant proteins in sporadic IPF and other interstitial lung diseases (ILDs) [<xref rid="bib-005" ref-type="bibr">5</xref>]. In addition to synthesizing surfactant proteins, type II alveolar cells are responsible for the constant regeneration of the alveolar epithelium, as precursors of the terminally differentiated type I cells. Surfactant protein C and A mutations have been shown to cause incorrect protein folding/processing, thereby activating the cell&#8217;s endoplasmic reticulum (ER) stress response. This is a stereotypical protective mechanism in response to the accumulation of misfolded proteins, ultimately leading to activation of apoptosis pathways [<xref rid="bib-006" ref-type="bibr">6</xref>,<xref rid="bib-007" ref-type="bibr">7</xref>]. Increased staining for markers of ER stress response and apoptosis is also observed in sporadic IPF [<xref rid="bib-008" ref-type="bibr">8</xref>,<xref rid="bib-009" ref-type="bibr">9</xref>], highlighting a prominent role for activation of the ER stress response and alveolar cell apoptosis in pathogenesis.</p><p>Type II cells are also affected in the Hermansky-Pudlak syndrome (HPS), a genetic disease frequently associated with lung fibrosis. HPS is caused by mutations in genes encoding for proteins involved in lysosome-related intracellular trafficking, leading to giant lamellar body formation in type II alveolar cells [<xref rid="bib-010" ref-type="bibr">10</xref>]. Although alveolar epithelial ER stress has been described in HPS lung fibrosis [<xref rid="bib-011" ref-type="bibr">11</xref>], Young and colleagues report that impaired intracellular trafficking pathways do not directly result in ER stress, suggesting further studies are needed to evaluate mechanisms [<xref rid="bib-012" ref-type="bibr">12</xref>].</p></sec><sec id="s02_2"><title>Telomere shortening</title><p>Pulmonary fibrosis occurs in a subset of patients with dyskeratosis congenita, a rare genetic disorder. Rapidly dividing tissues are affected, including epithelial cells and bone marrow, secondary to mutations in genes encoding for telomerase enzyme components. Telomerases are responsible for the elongation of telomeres, repetitive DNA sequences capping chromosome ends. Telomeres shorten at each cell replication until a critical length is reached, triggering a DNA damage response, leading to cellular senescence or apoptosis. Loss of telomerase activity reduces the renewal potential of stem cell populations [<xref rid="bib-013" ref-type="bibr">13</xref>]. Rare mutations in the telomerase genes <italic>TERT</italic> and <italic>TERC</italic> have been identified in approximately 8% of familial cases and in 1% to 3% of sporadic cases [<xref rid="bib-014" ref-type="bibr">14</xref>,<xref rid="bib-015" ref-type="bibr">15</xref>]. Telomeres shorten with age, and telomere dysfunction may be involved in a number of age-related degenerative disorders [<xref rid="bib-016" ref-type="bibr">16</xref>]. Even in the absence of <italic>TERT</italic>/<italic>TERC</italic> mutations, a proportion of IPF patients have shorter telomeres compared with age-matched controls [<xref rid="bib-017" ref-type="bibr">17</xref>,<xref rid="bib-018" ref-type="bibr">18</xref>]. In aggregate, these findings suggest that IPF may be a disease of accelerated aging in the lung, at least in the subset characterized by shortened telomeres. However, shorter telomeres in circulating leukocytes compared with age-matched control populations are also observed in chronic obstructive pulmonary disease (COPD), in asthma, and in association with lower lung function in control individuals, suggesting that the phenomenon of premature aging is not specific to pulmonary fibrosis [<xref rid="bib-019" ref-type="bibr">19</xref>].</p><p>The mechanisms through which telomere/telomerase defects may lead to pulmonary fibrosis are not well known. As telomerase dysfunction is most likely to affect cells with high turnover, epithelial cells are obvious candidates. Indeed, IPF alveolar epithelium had shorter telomeres than normal control epithelium, independently of detectable telomerase mutations in one study [<xref rid="bib-017" ref-type="bibr">17</xref>], although further studies are needed to confirm this interesting observation. Telomerase activity may differ according to cell type as increased telomerase activity has been reported in IPF lung fibroblasts, which is in keeping with potential increased survival and resistance to apoptosis in these cells [<xref rid="bib-020" ref-type="bibr">20</xref>].</p></sec><sec id="s02_3"><title>Bronchiolar cells</title><p>A prominent role for activated bronchiolar-type epithelial cells was first proposed by Chilosi and colleagues, in a study reporting activation of the Wnt/beta-catenin/matrylisin developmental pathway in hyperplastic bronchiolar lesions [<xref rid="bib-021" ref-type="bibr">21</xref>]. This was a feature seen in IPF but not in other ILD patterns, in contrast with nuclear beta-catenin expression observed in type II pneumocytes across ILDs. A particularly strong beta-catenin staining in areas of bronchiolization was confirmed by Konigshoff and colleagues [<xref rid="bib-022" ref-type="bibr">22</xref>].</p><p>In genetic studies, a role for bronchiolar cells has been suggested by the finding of a marked increase in a <italic>MUC5B</italic> gene common promoter polymorphism in familial interstitial pneumonia (FIP) and sporadic IPF compared with controls (minor allele present in 33.8% of FIP cases, 37.5% of sporadic IPF cases, and 9.1% of control subjects) [<xref rid="bib-023" ref-type="bibr">23</xref>,<xref rid="bib-024" ref-type="bibr">24</xref>]. This strong association suggests the pathogenetic significance of mucins/small airways in IPF. By contrast, no association was found between <italic>MUC5B</italic> and scleroderma-associated lung fibrosis or with fibrotic sarcoidosis, suggesting that this association may be specific to the idiopathic ILDs [<xref rid="bib-025" ref-type="bibr">25</xref>,<xref rid="bib-026" ref-type="bibr">26</xref>].</p><p>Although the <italic>MUC5B</italic> variants are associated with overexpression in lung tissue compared with non-carriers in control subjects, this is not the case in IPF, where lung <italic>MUC5B</italic> overexpression is seen independently of genetic variants [<xref rid="bib-023" ref-type="bibr">23</xref>]. This observation suggests that, in the absence of (or in addition to) <italic>MUC5B</italic> genetic variation, other environmental or genetic factors (or both) linked to disease pathogenesis cause its upregulation. MUC5B appears to localize mainly to the distal airways and to the honeycomb cysts in what appear to be bronchiolar cells rather than type II alveolar cells [<xref rid="bib-027" ref-type="bibr">27</xref>]. Honeycombing lesions would therefore derive from the dilatation of the small airways, an observation that was originally made more than 50 years ago [<xref rid="bib-028" ref-type="bibr">28</xref>]. The mucin-producing cells in the honeycombed areas are characterized by a transcription factor and mucin profile suggestive of abnormal programming, with a phenotype similar to that of submucosal gland goblet cells, normally not found in the distal airspaces [<xref rid="bib-029" ref-type="bibr">29</xref>]. The mechanism by which <italic>MUC5B</italic> polymorphisms predispose individuals to pulmonary fibrosis is not known. One of the hypotheses is that <italic>MUC5B</italic> variants may lead to impaired clearance of inhaled micro-organisms and other particles and therefore an aberrant innate response, although a direct toxic effect on epithelial cells and/or ectopic expression with intracellular accumulation and resulting ER stress response are also possibilities [<xref rid="bib-023" ref-type="bibr">23</xref>,<xref rid="bib-030" ref-type="bibr">30</xref>].</p><p>Interestingly, while <italic>MUC5B</italic> overexpression is associated with IPF independently of the genetic polymorphisms, the <italic>MUC5B</italic> genetic variant actually appears to be associated with slower progression and better survival [<xref rid="bib-026" ref-type="bibr">26</xref>,<xref rid="bib-031" ref-type="bibr">31</xref>], suggesting that it marks a subset of the disease. There is a known variability in the clinical course of IPF, ranging from prolonged stability/gradual worsening to rapid stepwise progression [<xref rid="bib-032" ref-type="bibr">32</xref>&#8211;<xref rid="bib-034" ref-type="bibr">34</xref>]. Disease subsets are also suggested by a recent whole-genome expression analysis in a large number of IPF biopsies [<xref rid="bib-035" ref-type="bibr">35</xref>]. Clustering of the genes differentially expressed compared with controls reveals a separation into two clear IPF subpopulations, based on a distinct molecular signature. One IPF group is characterized by overexpression (compared with the other) of a number of genes already known to be upregulated in IPF, including osteopontin, matrix metalloprotease 1 (<italic>MMP1</italic>), <italic>MMP7</italic>, and <italic>MUC5B</italic>. The same IPF group is also characterized by upregulation of a large number of transcripts associated with cilium genes. These include structural components such as axonemal dyneins involved in ciliary motility as well as transcription factors regulating cilium gene expression, including <italic>RFX3</italic>, <italic>FOXJ1</italic>, and <italic>RFX2</italic>. Patients with high cilium gene expression demonstrate more microscopic honeycombing but not more fibroblastic foci on lung biopsy [<xref rid="bib-035" ref-type="bibr">35</xref>]. These observations reinforce the role played by airway cells (at least in a subset) and for the first time provide molecular evidence that IPF may in fact consist of more than one disease, each with likely different pathogenesis, prognosis, and treatment responses. The authors do not mention whether these two subsets separate out according to the <italic>MUC5B</italic> polymorphisms or whether they are characterized by different longitudinal behavior, and no doubt further studies will shed light on this.</p><p>Two recent large genome-wide case-control association studies have confirmed the association with <italic>MUC5B</italic> [<xref rid="bib-036" ref-type="bibr">36</xref>,<xref rid="bib-037" ref-type="bibr">37</xref>], with the study by Fingerlin and colleagues [<xref rid="bib-036" ref-type="bibr">36</xref>] also identifying associations with common variants in the <italic>TERT</italic> and <italic>TERC</italic> genes. Both studies also report associations with several novel common gene variants. Among these, Fingerlin and colleagues report an association with genes involved in epithelial integrity and cell-cell adhesion, including desmoplakin (<italic>DSP</italic>) and <italic>DPP9</italic>, suggesting that defects in cell-cell adhesion or cellular cytoskeleton (or both) could predispose patients to injury in response to stimuli, including mechanical stretch. Both studies report an association with <italic>TOLLIP</italic>, a regulator of innate immune responses involved in modulating Toll-like receptor (TLR) signaling. The <italic>TOLLIP</italic> gene resides close to <italic>MUC5B</italic>, and variants in the two genes are in weak linkage disequilibrium. Once the <italic>MUC5B</italic> variants were included in the analysis, the association with the <italic>TOLLIP</italic> gene single-nucleotide polymorphisms (SNPs) only just reached statistical significance in the study by Noth and colleagues [<xref rid="bib-037" ref-type="bibr">37</xref>] (<italic>P</italic> = 0.05) and was no longer significant in the study by Fingerlin and colleagues, indicating the need for further studies. Interestingly, the minor allele of one of the <italic>TOLLIP</italic> SNPs (rs5743890) found to be protective toward lung fibrosis was associated with worse survival. This finding was maintained on adjusting for other gene variants, although <italic>MUC5B</italic> was not included in the multivariate analysis [<xref rid="bib-037" ref-type="bibr">37</xref>]. Again, whether the <italic>TOLLIP</italic> variant is a prognostic determinant, independently of <italic>MUC5B</italic>, remains to be determined.</p></sec></sec><sec id="s03"><title>Gene expression and epigenetic regulation</title><p>Transcriptional profiling studies of fibrotic lung tissues have identified key differences with control tissues and between different fibrotic ILD patterns [<xref rid="bib-038" ref-type="bibr">38</xref>&#8211;<xref rid="bib-041" ref-type="bibr">41</xref>]. Matrilysin (MMP7), one of the downstream targets of Wnt/beta-catenin, is highly overexpressed in IPF biopsies [<xref rid="bib-038" ref-type="bibr">38</xref>] and has been investigated as a peripheral blood biomarker in ILD. In the largest prospective biomarker study performed so far in IPF, MMP7, together with intercellular adhesion molecule-1 (ICAM-1) and interleukin-8 (IL-8), was the strongest predictor of survival in combination with clinical characteristics [<xref rid="bib-042" ref-type="bibr">42</xref>]. Boon and colleagues reported on upregulation in pathways involved in cell growth, proliferation, and migration in lung tissue from rapidly progressive compared with relatively stable IPF [<xref rid="bib-043" ref-type="bibr">43</xref>], suggesting that there may be common pathways between lung fibrosis and cancer development [<xref rid="bib-044" ref-type="bibr">44</xref>]. Rapidly progressive fibrosis was also characterized by upregulation of PLUNC, a molecule expressed mainly by secretory bronchial columnar cells, again highlighting a potential role for airway/innate defense functions [<xref rid="bib-043" ref-type="bibr">43</xref>]. With regard to fibroblasts, these are the main effector cell types involved in the fibrotic process [<xref rid="bib-045" ref-type="bibr">45</xref>], regardless of the initiating triggers. Gene expression profiling studies of cultured lung fibroblasts show specific pathways of activation [<xref rid="bib-046" ref-type="bibr">46</xref>&#8211;<xref rid="bib-048" ref-type="bibr">48</xref>], which appear to be similar in IPF and in scleroderma-associated ILD [<xref rid="bib-048" ref-type="bibr">48</xref>].</p><p>Although the study of epigenetic regulation in IPF is relatively recent, analysis in lung tissue or in IPF fibroblasts (or both) of the global and individual gene expression regulation through methylation [<xref rid="bib-049" ref-type="bibr">49</xref>&#8211;<xref rid="bib-051" ref-type="bibr">51</xref>], acetylation [<xref rid="bib-052" ref-type="bibr">52</xref>,<xref rid="bib-053" ref-type="bibr">53</xref>], and regulatory microRNAs [<xref rid="bib-054" ref-type="bibr">54</xref>&#8211;<xref rid="bib-061" ref-type="bibr">61</xref>] is providing information on regulatory networks and should allow a better understanding of how particular genetic variants and environmental exposures interact to cause pulmonary fibrosis, ultimately leading to novel treatment strategies.</p></sec><sec id="s04"><title>Innate and adaptive immune responses</title><p>The role played by conventional inflammation in IPF pathogenesis has been questioned, mainly in view of the lack of response to corticosteroids and immunosuppressants, which may indeed be harmful in patients with IPF [<xref rid="bib-062" ref-type="bibr">62</xref>]. However, components of the innate and adaptive immune response are thought to contribute to the pathogenesis of lung fibrosis.</p><p>The innate immune system plays a crucial role in initiating and terminating inflammatory responses to endogenous and exogenous noxious stimuli. The alveolar macrophage is a potential source of chemokines and growth factors that regulate the wound-healing response. Macrophages are characterized by at least two phenotypes: M1, induced by Th1 cytokines such as interferon, and expressing IL-12, tumor necrosis factor (TNF), and C-X-C motif chemokine (CXCL)10, and M2 (or alternatively activated M), which expresses CD163, mannose receptors, and secretes increased levels of IL-10, chemokine (C-C motif) ligand (CCL)18, and CCL22 [<xref rid="bib-063" ref-type="bibr">63</xref>]. Two carefully conducted large prospective studies have shown that bronchoalveolar lavage (BAL) and serum levels of CCL18, one of the markers of M2 macrophages, are significantly linked to extent of fibrosis and predict likelihood of progression, even after adjustment for disease severity, both in IPF and in systemic sclerosis-ILD [<xref rid="bib-064" ref-type="bibr">64</xref>,<xref rid="bib-065" ref-type="bibr">65</xref>].</p><p>Pattern recognition receptors, including TLRs, recognize pathogen and endogenous patterns, activate innate and adaptive immune responses, and participate in regulating wound healing [<xref rid="bib-066" ref-type="bibr">66</xref>]. Pathogen-associated molecular patterns (PAMPs) are suspected to play a role in the activation of fibroblasts through TLRs as well as nucleotide-binding oligomerization domain-like receptors (NLR)s and retinoic acid-inducible gene-1 (RIG-1) receptors [<xref rid="bib-067" ref-type="bibr">67</xref>]. Endogenous ligands can also be identified by TLRs, including components of the extracellular matrix such as hyaluronic acid [<xref rid="bib-068" ref-type="bibr">68</xref>], and fibrinogen degradation products [<xref rid="bib-069" ref-type="bibr">69</xref>]. Interestingly, the ligation of the latter to TLR4 has been shown to induce upregulation of mucin <italic>MUC5AC</italic> expression in both alveolar macrophages and epithelial cells [<xref rid="bib-069" ref-type="bibr">69</xref>].</p><p><italic>TLR9</italic> expression has been found to be increased in ILD lung tissue and in IPF fibroblasts compared with control subjects [<xref rid="bib-070" ref-type="bibr">70</xref>,<xref rid="bib-071" ref-type="bibr">71</xref>]. In particular, in both usual interstitial pneumonia (UIP) and non-specific interstitial pneumonia (NSIP), the increased expression is localized to areas of fibrosis in the epithelium and interstitium [<xref rid="bib-070" ref-type="bibr">70</xref>]. TLR9 activation by hypomethylated DNA significantly increased alpha smooth muscle actin [<xref rid="bib-070" ref-type="bibr">70</xref>] and promoted profibrotic cytokine and chemokine synthesis in IPF fibroblasts in culture [<xref rid="bib-072" ref-type="bibr">72</xref>]. TLR9 was particularly upregulated in the lung tissues of rapidly progressive IPF compared with more stable disease [<xref rid="bib-073" ref-type="bibr">73</xref>].</p><p>TLR3 has been shown to act as a sensor of tissue necrosis during acute inflammation. In addition, it recognizes virus-associated molecular patterns and activates pro-inflammatory cascades [<xref rid="bib-074" ref-type="bibr">74</xref>,<xref rid="bib-075" ref-type="bibr">75</xref>]. Recently, a <italic>TLR3</italic> polymorphism (TLR3L412F) associated with defective function of the receptor was studied in patients with IPF. Fibroblasts homozygous for the variant allele had an impaired interferon-beta response, displaying enhanced proliferation after TLR3 stimulation, partially corrected after interferon-beta treatment. Furthermore, the variant was associated with disease progression or early mortality (or both) in two separate IPF cohorts, with an additive effect for each allele [<xref rid="bib-076" ref-type="bibr">76</xref>]. This study is another example of a genetic variant linked to outcome in IPF and highlights the possibility of differences in response to treatments in different subsets, as suggested by the editorial accompanying the article [<xref rid="bib-077" ref-type="bibr">77</xref>]. The activation of TLRs in epithelial and interstial cells could be one of the links between exogenous/endogenous noxious signals and amplification of immune and fibroproliferative responses. Further studies are needed to assess their role in the pathogenesis of pulmonary fibrosis.</p><p>Adaptive immunity is also likely to be involved in IPF progression. We know that in hypersensitivity pneumonitis (HP) adaptive immunity is a crucial driver of disease. A proportion of patients with fibrotic HP have a UIP histology and can display an IPF-like disease course [<xref rid="bib-078" ref-type="bibr">78</xref>], although features such as airway centeredness of fibrosis and excess inflammation suggest the diagnosis of HP-associated UIP [<xref rid="bib-079" ref-type="bibr">79</xref>]. There may be at least a subset of patients with IPF in whom the fibrotic response is a response to an unknown antigen, with a role played by adaptive immunity. Indeed, Gilani and colleagues found that increased proportions of circulating CD28<sup>null</sup>CD4<sup>+</sup> T cells are associated with poor outcomes in patients with IPF [<xref rid="bib-080" ref-type="bibr">80</xref>]. CD28<sup>null</sup>CD4<sup>+</sup> cells are effector memory T cells, which develop as a result of repeated antigen-driven proliferations. These cells display increased production of cytotoxic mediators and pro-inflammatory cytokines, in keeping with enhanced noxious potential. Interestingly, CD28<sup>null</sup> T-cell telomeres are shortened as a result of repetitive T-cell clonal proliferations [<xref rid="bib-081" ref-type="bibr">81</xref>], and T cells comprise 40% to 50% of peripheral blood monocytes. This could contribute to findings of telomere shortening in the peripheral blood leukocytes of IPF patients and other populations with chronic disease. The relevance of T-cell differentiation in IPF, again as a result of repetitive antigen stimulation, is also supported by a recent report by Herazo-Maya and colleagues [<xref rid="bib-082" ref-type="bibr">82</xref>]. BAL and lung tissue-activated CD4<sup>+</sup> T cells are observed in asymptomatic early familial ILD cases [<xref rid="bib-083" ref-type="bibr">83</xref>], and pro-inflammatory dendritic cells are found in advanced lung fibrosis [<xref rid="bib-084" ref-type="bibr">84</xref>]. In IPF lungs, CD8<sup>+</sup> T lymphocytes correlated with degree of breathlessness and functional severity [<xref rid="bib-085" ref-type="bibr">85</xref>]. IPF lung-derived proteins induce proliferation of autologous CD4 T cells from these patients [<xref rid="bib-086" ref-type="bibr">86</xref>]. Semaphorin 7a<sup>+</sup> regulatory T cells are increased in the blood of patients with rapidly progressive IPF [<xref rid="bib-087" ref-type="bibr">87</xref>].</p><p>In addition to T cells, B cells may also be involved in IPF pathogenesis. Auto-antibodies against heat shock protein 70 (HSP 70) are associated with short-term deterioration in patients with IPF, independently of disease severity, suggesting a potential link to a pathogenetically significant process [<xref rid="bib-088" ref-type="bibr">88</xref>]. The finding of lymphoid follicles in IPF biopsies has been reported in a number of studies [<xref rid="bib-089" ref-type="bibr">89</xref>-<xref rid="bib-091" ref-type="bibr">91</xref>]. The presence of B-cell aggregates in injured tissues suggests a possible direct contribution of the significant pathogenetic potential of B cells to the fibrotic process [<xref rid="bib-092" ref-type="bibr">92</xref>]. Xue and colleagues observed an increase in circulating antigen-differentiated plasma cells in IPF patients and overexpression of a specific B-cell trophic factor (plasma B lymphocyte-stimulating factor), associated with poor short-term outcome [<xref rid="bib-090" ref-type="bibr">90</xref>]. A chemokine that mediates B-cell trafficking, CXCL13, was increased in the lung tissue and peripheral blood of IPF patients compared with healthy controls and COPD patients and was predictive of early mortality, further supporting a pathogenetic role for B cells [<xref rid="bib-093" ref-type="bibr">93</xref>].</p><p>It seems likely that both the innate and adaptive immune systems participate in lung fibrosis progression. However, the question of whether the hyperstimulation of the immune system described above is directly causative of lung fibrosis rather than a consequence of the loss of the normal lung architecture and therefore of natural defenses is more difficult to resolve. We should also consider the possibility of an interaction between the different pathogenetic mechanisms. For example, Agrawal and colleagues recently observed that an interaction between surfactant protein <bold>(</bold>SP)-A and TLR2 is involved in regulating secretion of pro-inflammatory mediators in macrophage lines both <italic>in vitro</italic> and <italic>in vivo</italic> [<xref rid="bib-094" ref-type="bibr">94</xref>].</p></sec><sec id="s05"><title>The clotting cascade</title><p>The clotting cascade appears to be activated in pulmonary fibrosis, as suggested by <italic>in vitro</italic> and animal model studies [<xref rid="bib-095" ref-type="bibr">95</xref>]. Cleaved clotting factors have major pro-inflammatory and profibrogenic effects [<xref rid="bib-096" ref-type="bibr">96</xref>], and activated platelets/endothelial cells release fibrogenic mediators, including platelet-derived growth factor (PDGF) and transforming growth factor-beta (TGF&#946;) [<xref rid="bib-097" ref-type="bibr">97</xref>]. Navaratnam and colleagues recently reported on a carefully conducted case-control study of 211 incident IPF cases to evaluate the incidence of clotting abnormalities identified through a pro-thrombotic panel of 11 clotting defects [<xref rid="bib-098" ref-type="bibr">98</xref>]. The authors found that patients with IPF have an almost fivefold greater chance of having at least one clotting abnormality, with incrementally increasing odds ratios for increasing numbers of clotting abnormalities. The highest odds ratios were seen for elevation of factor VIII levels (&gt;165 IU/dL in 124 out of 194 patients with IPF versus 45 out of 211 controls). Furthermore, clotting abnormalities were associated with more severe disease at baseline and a worse survival. How this fits with the recent trial of warfarin treatment in IPF, which was stopped early because of an increased rate of pulmonary fibrosis deterioration in the warfarin-treated arm [<xref rid="bib-099" ref-type="bibr">99</xref>], will need to be further investigated, but it does support previous studies pointing to an important role played by the coagulation system in the lung fibrosis process.</p></sec><sec id="s06"><title>Physical factors</title><p>Leslie recently proposed a unifying hypothesis for IPF as a disease of &#8220;recurrent stretch injury to the peripheral and basal lung occurring over many years in predisposed individuals&#8221; [<xref rid="bib-100" ref-type="bibr">100</xref>]. This theory attempts to reconcile a number of unexplained features, including the predominantly basal and subpleural distribution, the progression of the disease toward the apical regions, and the finding that fibroblastic foci are a continuum extending inward from the pleural surface (fibroblastic reticulum) [<xref rid="bib-101" ref-type="bibr">101</xref>]. IPF would start in the basal and peripheral regions of the lungs, where the alveoli are the smallest in the upright and supine positions and are therefore more likely to collapse in response to the tractional forces during respiration, as also suggested by Galvin and colleagues [<xref rid="bib-102" ref-type="bibr">102</xref>] and Dail [<xref rid="bib-103" ref-type="bibr">103</xref>]. Surfactant protein abnormalities could lead to increased surface tension and greater likelihood of alveolar collapse, while the reticular network of fibroblastic foci would occur along stress fractures/lines at the interface between the epithelium and the mesenchymal cells. A vicious circle of increasing alveolar surface tension causing further alveolar collapse and subsequent enlargement of the alveolar ducts leading to microscopic honeycombing would follow. Carloni and colleagues applied a mathematical model to verify whether the distribution of IPF lesions corresponds to the areas of greatest mechanical tension [<xref rid="bib-104" ref-type="bibr">104</xref>]. If these mechanical forces have a role in the origin or in the progression of the disease, they should also influence those cases with associated emphysema, which were initially described more than 20 years ago [<xref rid="bib-105" ref-type="bibr">105</xref>] and which only recently have attracted the attention of researchers [<xref rid="bib-106" ref-type="bibr">106</xref>]. In these cases, one would expect a lower traction in the basal zones because of reduced elastic recoil of the upper parts of the lung.</p></sec><sec sec-type="conclusions" id="s07"><title>Conclusion</title><p>In conclusion, genetic association studies suggest a pivotal pathogenetic role played by abnormal regeneration/differentiation potential of respiratory epithelial cells in IPF (both alveolar and bronchiolar), which is likely to be determined by the interaction between environmental exposures such as cigarette smoke and gene variants, including surfactant protein and telomerase genes. The association with <italic>MUC5B</italic> suggests a role of airway epithelial cells and mucins. Further studies on how molecular phenotypes can be linked in to genetic data and to clinical, radiological, and histological characteristics of the disease will be crucial to predict clinical course and drive novel treatments in IPF.</p></sec></body><back><notes><sec><title>Disclosures</title><p>The authors declare that they have no disclosures.</p></sec></notes><ref-list><title>References</title><ref id="bib-001"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nogee</surname><given-names>LM</given-names></name><name><surname>Dunbar</surname><given-names>AE</given-names></name><name><surname>Wert</surname><given-names>SE</given-names></name><name><surname>Askin</surname><given-names>F</given-names></name><name><surname>Hamvas</surname><given-names>A</given-names></name><name><surname>Whitsett</surname><given-names>JA</given-names></name></person-group><article-title>A mutation in the surfactant protein C gene associated with familial interstitial lung disease</article-title><source>N Engl J Med</source><year>2001</year><volume>344</volume><fpage>573</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1056/NEJM200102223440805</pub-id><?supplied-pmid 11207353?><pub-id pub-id-type="pmid">11207353</pub-id></element-citation><note><p><ext-link ext-link-type="uri" xlink:href="http://f1000.com/prime/718489778">http://f1000.com/prime/718489778</ext-link></p></note></ref><ref id="bib-002"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>AQ</given-names></name><name><surname>Lane</surname><given-names>K</given-names></name><name><surname>Phillips</surname><given-names>J</given-names></name><name><surname>Prince</surname><given-names>M</given-names></name><name><surname>Markin</surname><given-names>C</given-names></name><name><surname>Speer</surname><given-names>M</given-names></name><name><surname>Schwartz</surname><given-names>DA</given-names></name><name><surname>Gaddipati</surname><given-names>R</given-names></name><name><surname>Marney</surname><given-names>A</given-names></name><name><surname>Johnson</surname><given-names>J</given-names></name><name><surname>Roberts</surname><given-names>R</given-names></name><name><surname>Haines</surname><given-names>J</given-names></name><name><surname>Stahlman</surname><given-names>M</given-names></name><name><surname>Loyd</surname><given-names>JE</given-names></name></person-group><article-title>Heterozygosity for a surfactant protein C gene mutation associated with usual interstitial pneumonitis and cellular nonspecific interstitial pneumonitis in one kindred</article-title><source>Am J Respir Crit Care Med</source><year>2002</year><volume>165</volume><fpage>1322</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1164/rccm.200112-123OC</pub-id><?supplied-pmid 11991887?><pub-id pub-id-type="pmid">11991887</pub-id></element-citation><note><p><ext-link ext-link-type="uri" xlink:href="http://f1000.com/prime/718489779">http://f1000.com/prime/718489779</ext-link></p></note></ref><ref id="bib-003"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Markart</surname><given-names>P</given-names></name><name><surname>Ruppert</surname><given-names>C</given-names></name><name><surname>Wygrecka</surname><given-names>M</given-names></name><name><surname>Schmidt</surname><given-names>R</given-names></name><name><surname>Korfei</surname><given-names>M</given-names></name><name><surname>Harbach</surname><given-names>H</given-names></name><name><surname>Theruvath</surname><given-names>I</given-names></name><name><surname>Pison</surname><given-names>U</given-names></name><name><surname>Seeger</surname><given-names>W</given-names></name><name><surname>Guenther</surname><given-names>A</given-names></name><name><surname>Witt</surname><given-names>H</given-names></name></person-group><article-title>Surfactant protein C mutations in sporadic forms of idiopathic interstitial pneumonias</article-title><source>Eur Respir J</source><year>2007</year><volume>29</volume><fpage>134</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1183/09031936.00034406</pub-id><?supplied-pmid 17005585?><pub-id pub-id-type="pmid">17005585</pub-id></element-citation><note><p><ext-link ext-link-type="uri" xlink:href="http://f1000.com/prime/718489780">http://f1000.com/prime/718489780</ext-link></p></note></ref><ref id="bib-004"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lawson</surname><given-names>WE</given-names></name><name><surname>Grant</surname><given-names>SW</given-names></name><name><surname>Ambrosini</surname><given-names>V</given-names></name><name><surname>Womble</surname><given-names>KE</given-names></name><name><surname>Dawson</surname><given-names>EP</given-names></name><name><surname>Lane</surname><given-names>KB</given-names></name><name><surname>Markin</surname><given-names>C</given-names></name><name><surname>Renzoni</surname><given-names>E</given-names></name><name><surname>Lympany</surname><given-names>P</given-names></name><name><surname>Thomas</surname><given-names>AQ</given-names></name><name><surname>Roldan</surname><given-names>J</given-names></name><name><surname>Scott</surname><given-names>TA</given-names></name><name><surname>Blackwell</surname><given-names>TS</given-names></name><name><surname>Phillips</surname><given-names>JA</given-names></name><name><surname>Loyd</surname><given-names>JE</given-names></name><name><surname>du Bois</surname><given-names>RM</given-names></name></person-group><article-title>Genetic mutations in surfactant protein C are a rare cause of sporadic cases of IPF</article-title><source>Thorax</source><year>2004</year><volume>59</volume><fpage>977</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1136/thx.2004.026336</pub-id><?supplied-pmid 15516475?><pub-id pub-id-type="pmid">15516475</pub-id></element-citation></ref><ref id="bib-005"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Kaminski</surname><given-names>N</given-names></name></person-group><article-title>Biomarkers in idiopathic pulmonary fibrosis</article-title><source>Curr Opin Pulm Med</source><year>2012</year><volume>18</volume><fpage>441</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1097/MCP.0b013e328356d03c</pub-id><?supplied-pmid 22847105?><pub-id pub-id-type="pmid">22847105</pub-id></element-citation></ref><ref id="bib-006"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kabore</surname><given-names>AF</given-names></name><name><surname>Wang</surname><given-names>WJ</given-names></name><name><surname>Russo</surname><given-names>SJ</given-names></name><name><surname>Beers</surname><given-names>MF</given-names></name></person-group><article-title>Biosynthesis of surfactant protein C: characterization of aggresome formation by EGFP chimeras containing propeptide mutants lacking conserved cysteine residues</article-title><source>J Cell Sci</source><year>2001</year><volume>114</volume><fpage>293</fpage><lpage>302</lpage><?supplied-pmid 11148131?><pub-id pub-id-type="pmid">11148131</pub-id></element-citation></ref><ref id="bib-007"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mulugeta</surname><given-names>S</given-names></name><name><surname>Nguyen</surname><given-names>V</given-names></name><name><surname>Russo</surname><given-names>SJ</given-names></name><name><surname>Muniswamy</surname><given-names>M</given-names></name><name><surname>Beers</surname><given-names>MF</given-names></name></person-group><article-title>A surfactant protein C precursor protein BRICHOS domain mutation causes endoplasmic reticulum stress, proteasome dysfunction, and caspase 3 activation</article-title><source>Am J Respir Cell Mol Biol</source><year>2005</year><volume>32</volume><fpage>521</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1165/rcmb.2005-0009OC</pub-id><?supplied-pmid 15778495?><pub-id pub-id-type="pmid">15778495</pub-id></element-citation></ref><ref id="bib-008"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lawson</surname><given-names>WE</given-names></name><name><surname>Crossno</surname><given-names>PF</given-names></name><name><surname>Polosukhin</surname><given-names>VV</given-names></name><name><surname>Roldan</surname><given-names>J</given-names></name><name><surname>Cheng</surname><given-names>D</given-names></name><name><surname>Lane</surname><given-names>KB</given-names></name><name><surname>Blackwell</surname><given-names>TR</given-names></name><name><surname>Xu</surname><given-names>C</given-names></name><name><surname>Markin</surname><given-names>C</given-names></name><name><surname>Ware</surname><given-names>LB</given-names></name><name><surname>Miller</surname><given-names>GG</given-names></name><name><surname>Loyd</surname><given-names>JE</given-names></name><name><surname>Blackwell</surname><given-names>TS</given-names></name></person-group><article-title>Endoplasmic reticulum stress in alveolar epithelial cells is prominent in IPF: association with altered surfactant protein processing and herpesvirus infection</article-title><source>Am J Physiol Lung Cell Mol Physiol</source><year>2008</year><volume>294</volume><fpage>L1119</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1152/ajplung.00382.2007</pub-id><?supplied-pmid 18390830?><pub-id pub-id-type="pmid">18390830</pub-id></element-citation></ref><ref id="bib-009"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Korfei</surname><given-names>M</given-names></name><name><surname>Ruppert</surname><given-names>C</given-names></name><name><surname>Mahavadi</surname><given-names>P</given-names></name><name><surname>Henneke</surname><given-names>I</given-names></name><name><surname>Markart</surname><given-names>P</given-names></name><name><surname>Koch</surname><given-names>M</given-names></name><name><surname>Lang</surname><given-names>G</given-names></name><name><surname>Fink</surname><given-names>L</given-names></name><name><surname>Bohle</surname><given-names>R</given-names></name><name><surname>Seeger</surname><given-names>W</given-names></name><name><surname>Weaver</surname><given-names>TE</given-names></name><name><surname>Guenther</surname><given-names>A</given-names></name></person-group><article-title>Epithelial endoplasmic reticulum stress and apoptosis in sporadic idiopathic pulmonary fibrosis</article-title><source>Am J Respir Crit Care Med</source><year>2008</year><volume>178</volume><fpage>838</fpage><lpage>46</lpage><pub-id pub-id-type="doi">10.1164/rccm.200802-313OC</pub-id><?supplied-pmid 18635891?><pub-id pub-id-type="pmid">18635891</pub-id></element-citation><note><p><ext-link ext-link-type="uri" xlink:href="http://f1000.com/prime/1145273">http://f1000.com/prime/1145273</ext-link></p></note></ref><ref id="bib-010"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakatani</surname><given-names>Y</given-names></name><name><surname>Nakamura</surname><given-names>N</given-names></name><name><surname>Sano</surname><given-names>J</given-names></name><name><surname>Inayama</surname><given-names>Y</given-names></name><name><surname>Kawano</surname><given-names>N</given-names></name><name><surname>Yamanaka</surname><given-names>S</given-names></name><name><surname>Miyagi</surname><given-names>Y</given-names></name><name><surname>Nagashima</surname><given-names>Y</given-names></name><name><surname>Ohbayashi</surname><given-names>C</given-names></name><name><surname>Mizushima</surname><given-names>M</given-names></name><name><surname>Manabe</surname><given-names>T</given-names></name><name><surname>Kuroda</surname><given-names>M</given-names></name><name><surname>Yokoi</surname><given-names>T</given-names></name><name><surname>Matsubara</surname><given-names>O</given-names></name></person-group><article-title>Interstitial pneumonia in Hermansky-Pudlak syndrome: significance of florid foamy swelling/degeneration (giant lamellar body degeneration) of type-2 pneumocytes</article-title><source>Virchows Arch</source><year>2000</year><volume>437</volume><fpage>304</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1007/s004280000241</pub-id><?supplied-pmid 11037352?><pub-id pub-id-type="pmid">11037352</pub-id></element-citation></ref><ref id="bib-011"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahavadi</surname><given-names>P</given-names></name><name><surname>Korfei</surname><given-names>M</given-names></name><name><surname>Henneke</surname><given-names>I</given-names></name><name><surname>Liebisch</surname><given-names>G</given-names></name><name><surname>Schmitz</surname><given-names>G</given-names></name><name><surname>Gochuico</surname><given-names>BR</given-names></name><name><surname>Markart</surname><given-names>P</given-names></name><name><surname>Bellusci</surname><given-names>S</given-names></name><name><surname>Seeger</surname><given-names>W</given-names></name><name><surname>Ruppert</surname><given-names>C</given-names></name><name><surname>Guenther</surname><given-names>A</given-names></name></person-group><article-title>Epithelial stress and apoptosis underlie Hermansky-Pudlak syndrome-associated interstitial pneumonia</article-title><source>Am J Respir Crit Care Med</source><year>2010</year><volume>182</volume><fpage>207</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1164/rccm.200909-1414OC</pub-id><?supplied-pmid 20378731?><pub-id pub-id-type="pmid">20378731</pub-id></element-citation></ref><ref id="bib-012"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Young</surname><given-names>LR</given-names></name><name><surname>Gulleman</surname><given-names>PM</given-names></name><name><surname>Bridges</surname><given-names>JP</given-names></name><name><surname>Weaver</surname><given-names>TE</given-names></name><name><surname>Deutsch</surname><given-names>GH</given-names></name><name><surname>Blackwell</surname><given-names>TS</given-names></name><name><surname>McCormack</surname><given-names>FX</given-names></name></person-group><article-title>The alveolar epithelium determines susceptibility to lung fibrosis in Hermansky-Pudlak syndrome</article-title><source>Am J Respir Crit Care Med</source><year>2012</year><volume>186</volume><fpage>1014</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1164/rccm.201207-1206OC</pub-id><?supplied-pmid 23043085?><pub-id pub-id-type="pmid">23043085</pub-id></element-citation><note><p><ext-link ext-link-type="uri" xlink:href="http://f1000.com/prime/717965536">http://f1000.com/prime/717965536</ext-link></p></note></ref><ref id="bib-013"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Batista</surname><given-names>Luis FZ</given-names></name><name><surname>Pech</surname><given-names>MF</given-names></name><name><surname>Zhong</surname><given-names>FL</given-names></name><name><surname>Nguyen</surname><given-names>HN</given-names></name><name><surname>Xie</surname><given-names>KT</given-names></name><name><surname>Zaug</surname><given-names>AJ</given-names></name><name><surname>Crary</surname><given-names>SM</given-names></name><name><surname>Choi</surname><given-names>J</given-names></name><name><surname>Sebastiano</surname><given-names>V</given-names></name><name><surname>Cherry</surname><given-names>A</given-names></name><name><surname>Giri</surname><given-names>N</given-names></name><name><surname>Wernig</surname><given-names>M</given-names></name><name><surname>Alter</surname><given-names>BP</given-names></name><name><surname>Cech</surname><given-names>TR</given-names></name><name><surname>Savage</surname><given-names>SA</given-names></name><name><surname>Reijo Pera</surname><given-names>Renee A</given-names></name><name><surname>Artandi</surname><given-names>SE</given-names></name></person-group><article-title>Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cells</article-title><source>Nature</source><year>2011</year><volume>474</volume><fpage>399</fpage><lpage>402</lpage><pub-id pub-id-type="doi">10.1038/nature10084</pub-id><?supplied-pmid 21602826?><pub-id pub-id-type="pmid">21602826</pub-id></element-citation></ref><ref id="bib-014"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Armanios</surname><given-names>MY</given-names></name><name><surname>Chen</surname><given-names>JJ</given-names></name><name><surname>Cogan</surname><given-names>JD</given-names></name><name><surname>Alder</surname><given-names>JK</given-names></name><name><surname>Ingersoll</surname><given-names>RG</given-names></name><name><surname>Markin</surname><given-names>C</given-names></name><name><surname>Lawson</surname><given-names>WE</given-names></name><name><surname>Xie</surname><given-names>M</given-names></name><name><surname>Vulto</surname><given-names>I</given-names></name><name><surname>Phillips</surname><given-names>JA</given-names></name><name><surname>Lansdorp</surname><given-names>PM</given-names></name><name><surname>Greider</surname><given-names>CW</given-names></name><name><surname>Loyd</surname><given-names>JE</given-names></name></person-group><article-title>Telomerase mutations in families with idiopathic pulmonary fibrosis</article-title><source>N Engl J Med</source><year>2007</year><volume>356</volume><fpage>1317</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa066157</pub-id><?supplied-pmid 17392301?><pub-id pub-id-type="pmid">17392301</pub-id></element-citation><note><p><ext-link ext-link-type="uri" xlink:href="http://f1000.com/prime/718489781">http://f1000.com/prime/718489781</ext-link></p></note></ref><ref id="bib-015"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsakiri</surname><given-names>KD</given-names></name><name><surname>Cronkhite</surname><given-names>JT</given-names></name><name><surname>Kuan</surname><given-names>PJ</given-names></name><name><surname>Xing</surname><given-names>C</given-names></name><name><surname>Raghu</surname><given-names>G</given-names></name><name><surname>Weissler</surname><given-names>JC</given-names></name><name><surname>Rosenblatt</surname><given-names>RL</given-names></name><name><surname>Shay</surname><given-names>JW</given-names></name><name><surname>Garcia</surname><given-names>CK</given-names></name></person-group><article-title>Adult-onset pulmonary fibrosis caused by mutations in telomerase</article-title><source>Proc Natl Acad Sci USA</source><year>2007</year><volume>104</volume><fpage>7552</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1073/pnas.0701009104</pub-id><?supplied-pmid 17460043?><pub-id pub-id-type="pmid">17460043</pub-id></element-citation><note><p><ext-link ext-link-type="uri" xlink:href="http://f1000.com/prime/1083021">http://f1000.com/prime/1083021</ext-link></p></note></ref><ref id="bib-016"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Armanios</surname><given-names>M</given-names></name><name><surname>Blackburn</surname><given-names>EH</given-names></name></person-group><article-title>The telomere syndromes</article-title><source>Nat Rev Genet</source><year>2012</year><volume>13</volume><fpage>693</fpage><lpage>704</lpage><pub-id pub-id-type="doi">10.1038/nrg3246</pub-id><?supplied-pmid 22965356?><pub-id pub-id-type="pmid">22965356</pub-id></element-citation></ref><ref id="bib-017"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alder</surname><given-names>JK</given-names></name><name><surname>Chen</surname><given-names>JJ</given-names></name><name><surname>Lancaster</surname><given-names>L</given-names></name><name><surname>Danoff</surname><given-names>S</given-names></name><name><surname>Su</surname><given-names>S</given-names></name><name><surname>Cogan</surname><given-names>JD</given-names></name><name><surname>Vulto</surname><given-names>I</given-names></name><name><surname>Xie</surname><given-names>M</given-names></name><name><surname>Qi</surname><given-names>X</given-names></name><name><surname>Tuder</surname><given-names>RM</given-names></name><name><surname>Phillips</surname><given-names>JA</given-names></name><name><surname>Lansdorp</surname><given-names>PM</given-names></name><name><surname>Loyd</surname><given-names>JE</given-names></name><name><surname>Armanios</surname><given-names>MY</given-names></name></person-group><article-title>Short telomeres are a risk factor for idiopathic pulmonary fibrosis</article-title><source>Proc Natl Acad Sci USA</source><year>2008</year><volume>105</volume><fpage>13051</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1073/pnas.0804280105</pub-id><?supplied-pmid 18753630?><pub-id pub-id-type="pmid">18753630</pub-id></element-citation><note><p><ext-link ext-link-type="uri" xlink:href="http://f1000.com/prime/1123109">http://f1000.com/prime/1123109</ext-link></p></note></ref><ref id="bib-018"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cronkhite</surname><given-names>JT</given-names></name><name><surname>Xing</surname><given-names>C</given-names></name><name><surname>Raghu</surname><given-names>G</given-names></name><name><surname>Chin</surname><given-names>KM</given-names></name><name><surname>Torres</surname><given-names>F</given-names></name><name><surname>Rosenblatt</surname><given-names>RL</given-names></name><name><surname>Garcia</surname><given-names>CK</given-names></name></person-group><article-title>Telomere shortening in familial and sporadic pulmonary fibrosis</article-title><source>Am J Respir Crit Care Med</source><year>2008</year><volume>178</volume><fpage>729</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1164/rccm.200804-550OC</pub-id><?supplied-pmid 18635888?><pub-id pub-id-type="pmid">18635888</pub-id></element-citation><note><p><ext-link ext-link-type="uri" xlink:href="http://f1000.com/prime/1130834">http://f1000.com/prime/1130834</ext-link></p></note></ref><ref id="bib-019"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Albrecht</surname><given-names>E</given-names></name><name><surname>Sillanp&#228;&#228;</surname><given-names>E</given-names></name><name><surname>Karrasch</surname><given-names>S</given-names></name><name><surname>Alves</surname><given-names>AC</given-names></name><name><surname>Codd</surname><given-names>V</given-names></name><name><surname>Hovatta</surname><given-names>I</given-names></name><name><surname>Buxton</surname><given-names>JL</given-names></name><name><surname>Nelson</surname><given-names>CP</given-names></name><name><surname>Broer</surname><given-names>L</given-names></name><name><surname>H&#228;gg</surname><given-names>S</given-names></name><name><surname>Mangino</surname><given-names>M</given-names></name><name><surname>Willemsen</surname><given-names>G</given-names></name><name><surname>Surakka</surname><given-names>I</given-names></name><name><surname>Ferreira</surname><given-names>Manuel AR</given-names></name><name><surname>Amin</surname><given-names>N</given-names></name><name><surname>Oostra</surname><given-names>BA</given-names></name><name><surname>B&#228;ckmand</surname><given-names>HM</given-names></name><name><surname>Peltonen</surname><given-names>M</given-names></name><name><surname>Sarna</surname><given-names>S</given-names></name><name><surname>Rantanen</surname><given-names>T</given-names></name><name><surname>Sipil&#228;</surname><given-names>S</given-names></name><name><surname>Korhonen</surname><given-names>T</given-names></name><name><surname>Madden</surname><given-names>Pamela AF</given-names></name><name><surname>Gieger</surname><given-names>C</given-names></name><name><surname>J&#246;rres</surname><given-names>RA</given-names></name><name><surname>Heinrich</surname><given-names>J</given-names></name><name><surname>Behr</surname><given-names>J</given-names></name><name><surname>Huber</surname><given-names>RM</given-names></name><name><surname>Peters</surname><given-names>A</given-names></name><name><surname>Strauch</surname><given-names>K</given-names></name><etal/></person-group><article-title>Telomere length in circulating leukocytes is associated with lung function and disease</article-title><source>Eur Respir J</source><year>2014</year><volume>43</volume><fpage>983</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1183/09031936.00046213</pub-id><?supplied-pmid 24311771?><pub-id pub-id-type="pmid">24311771</pub-id></element-citation></ref><ref id="bib-020"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>T</given-names></name><name><surname>Ullenbruch</surname><given-names>M</given-names></name><name><surname>Young Choi</surname><given-names>Y</given-names></name><name><surname>Yu</surname><given-names>H</given-names></name><name><surname>Ding</surname><given-names>L</given-names></name><name><surname>Xaubet</surname><given-names>A</given-names></name><name><surname>Pereda</surname><given-names>J</given-names></name><name><surname>Feghali-Bostwick</surname><given-names>CA</given-names></name><name><surname>Bitterman</surname><given-names>PB</given-names></name><name><surname>Henke</surname><given-names>CA</given-names></name><name><surname>Pardo</surname><given-names>A</given-names></name><name><surname>Selman</surname><given-names>M</given-names></name><name><surname>Phan</surname><given-names>SH</given-names></name></person-group><article-title>Telomerase and telomere length in pulmonary fibrosis</article-title><source>Am J Respir Cell Mol Biol</source><year>2013</year><volume>49</volume><fpage>260</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1165/rcmb.2012-0514OC</pub-id><?supplied-pmid 23526226?><pub-id pub-id-type="pmid">23526226</pub-id></element-citation><note><p><ext-link ext-link-type="uri" xlink:href="http://f1000.com/prime/717991917">http://f1000.com/prime/717991917</ext-link></p></note></ref><ref id="bib-021"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chilosi</surname><given-names>M</given-names></name><name><surname>Poletti</surname><given-names>V</given-names></name><name><surname>Zam&#242;</surname><given-names>A</given-names></name><name><surname>Lestani</surname><given-names>M</given-names></name><name><surname>Montagna</surname><given-names>L</given-names></name><name><surname>Piccoli</surname><given-names>P</given-names></name><name><surname>Pedron</surname><given-names>S</given-names></name><name><surname>Bertaso</surname><given-names>M</given-names></name><name><surname>Scarpa</surname><given-names>A</given-names></name><name><surname>Murer</surname><given-names>B</given-names></name><name><surname>Cancellieri</surname><given-names>A</given-names></name><name><surname>Maestro</surname><given-names>R</given-names></name><name><surname>Semenzato</surname><given-names>G</given-names></name><name><surname>Doglioni</surname><given-names>C</given-names></name></person-group><article-title>Aberrant Wnt/beta-catenin pathway activation in idiopathic pulmonary fibrosis</article-title><source>Am J Pathol</source><year>2003</year><volume>162</volume><fpage>1495</fpage><lpage>502</lpage><pub-id pub-id-type="doi">10.1016/S0002-9440(10)64282-4</pub-id><?supplied-pmid 12707032?><pub-id pub-id-type="pmid">12707032</pub-id></element-citation><note><p><ext-link ext-link-type="uri" xlink:href="http://f1000.com/prime/718489782">http://f1000.com/prime/718489782</ext-link></p></note></ref><ref id="bib-022"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>K&#246;nigshoff</surname><given-names>M</given-names></name><name><surname>Balsara</surname><given-names>N</given-names></name><name><surname>Pfaff</surname><given-names>E</given-names></name><name><surname>Kramer</surname><given-names>M</given-names></name><name><surname>Chrobak</surname><given-names>I</given-names></name><name><surname>Seeger</surname><given-names>W</given-names></name><name><surname>Eickelberg</surname><given-names>O</given-names></name></person-group><article-title>Functional Wnt signaling is increased in idiopathic pulmonary fibrosis</article-title><source>PLoS ONE</source><year>2008</year><volume>3</volume><fpage>e2142</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0002142</pub-id><?supplied-pmid 18478089?><pub-id pub-id-type="pmid">18478089</pub-id></element-citation></ref><ref id="bib-023"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seibold</surname><given-names>MA</given-names></name><name><surname>Wise</surname><given-names>AL</given-names></name><name><surname>Speer</surname><given-names>MC</given-names></name><name><surname>Steele</surname><given-names>MP</given-names></name><name><surname>Brown</surname><given-names>KK</given-names></name><name><surname>Loyd</surname><given-names>JE</given-names></name><name><surname>Fingerlin</surname><given-names>TE</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Gudmundsson</surname><given-names>G</given-names></name><name><surname>Groshong</surname><given-names>SD</given-names></name><name><surname>Evans</surname><given-names>CM</given-names></name><name><surname>Garantziotis</surname><given-names>S</given-names></name><name><surname>Adler</surname><given-names>KB</given-names></name><name><surname>Dickey</surname><given-names>BF</given-names></name><name><surname>du Bois</surname><given-names>Roland M</given-names></name><name><surname>Yang</surname><given-names>IV</given-names></name><name><surname>Herron</surname><given-names>A</given-names></name><name><surname>Kervitsky</surname><given-names>D</given-names></name><name><surname>Talbert</surname><given-names>JL</given-names></name><name><surname>Markin</surname><given-names>C</given-names></name><name><surname>Park</surname><given-names>J</given-names></name><name><surname>Crews</surname><given-names>AL</given-names></name><name><surname>Slifer</surname><given-names>SH</given-names></name><name><surname>Auerbach</surname><given-names>S</given-names></name><name><surname>Roy</surname><given-names>MG</given-names></name><name><surname>Lin</surname><given-names>J</given-names></name><name><surname>Hennessy</surname><given-names>CE</given-names></name><name><surname>Schwarz</surname><given-names>MI</given-names></name><name><surname>Schwartz</surname><given-names>DA</given-names></name></person-group><article-title>A common MUC5B promoter polymorphism and pulmonary fibrosis</article-title><source>N Engl J Med</source><year>2011</year><volume>364</volume><fpage>1503</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1013660</pub-id><?supplied-pmid 21506741?><pub-id pub-id-type="pmid">21506741</pub-id></element-citation><note><p><ext-link ext-link-type="uri" xlink:href="http://f1000.com/prime/10416956">http://f1000.com/prime/10416956</ext-link></p></note></ref><ref id="bib-024"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Noth</surname><given-names>I</given-names></name><name><surname>Garcia</surname><given-names>Joe GN</given-names></name><name><surname>Kaminski</surname><given-names>N</given-names></name></person-group><article-title>A variant in the promoter of MUC5B and idiopathic pulmonary fibrosis</article-title><source>N Engl J Med</source><year>2011</year><volume>364</volume><fpage>1576</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1056/NEJMc1013504</pub-id><?supplied-pmid 21506748?><pub-id pub-id-type="pmid">21506748</pub-id></element-citation><note><p><ext-link ext-link-type="uri" xlink:href="http://f1000.com/prime/718020072">http://f1000.com/prime/718020072</ext-link></p></note></ref><ref id="bib-025"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peljto</surname><given-names>AL</given-names></name><name><surname>Steele</surname><given-names>MP</given-names></name><name><surname>Fingerlin</surname><given-names>TE</given-names></name><name><surname>Hinchcliff</surname><given-names>ME</given-names></name><name><surname>Murphy</surname><given-names>E</given-names></name><name><surname>Podlusky</surname><given-names>S</given-names></name><name><surname>Carns</surname><given-names>M</given-names></name><name><surname>Schwarz</surname><given-names>M</given-names></name><name><surname>Varga</surname><given-names>J</given-names></name><name><surname>Schwartz</surname><given-names>DA</given-names></name></person-group><article-title>The pulmonary fibrosis-associated MUC5B promoter polymorphism does not influence the development of interstitial pneumonia in systemic sclerosis</article-title><source>Chest</source><year>2012</year><volume>142</volume><fpage>1584</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1378/chest.12-0110</pub-id><?supplied-pmid 22576636?><pub-id pub-id-type="pmid">22576636</pub-id></element-citation></ref><ref id="bib-026"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stock</surname><given-names>CJ</given-names></name><name><surname>Sato</surname><given-names>H</given-names></name><name><surname>Fonseca</surname><given-names>C</given-names></name><name><surname>Banya</surname><given-names>Winston AS</given-names></name><name><surname>Molyneaux</surname><given-names>PL</given-names></name><name><surname>Adamali</surname><given-names>H</given-names></name><name><surname>Russell</surname><given-names>A</given-names></name><name><surname>Denton</surname><given-names>CP</given-names></name><name><surname>Abraham</surname><given-names>DJ</given-names></name><name><surname>Hansell</surname><given-names>DM</given-names></name><name><surname>Nicholson</surname><given-names>AG</given-names></name><name><surname>Maher</surname><given-names>TM</given-names></name><name><surname>Wells</surname><given-names>AU</given-names></name><name><surname>Lindahl</surname><given-names>GE</given-names></name><name><surname>Renzoni</surname><given-names>EA</given-names></name></person-group><article-title>Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosis</article-title><source>Thorax</source><year>2013</year><volume>68</volume><fpage>436</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1136/thoraxjnl-2012-201786</pub-id><?supplied-pmid 23321605?><pub-id pub-id-type="pmid">23321605</pub-id></element-citation></ref><ref id="bib-027"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seibold</surname><given-names>MA</given-names></name><name><surname>Smith</surname><given-names>RW</given-names></name><name><surname>Urbanek</surname><given-names>C</given-names></name><name><surname>Groshong</surname><given-names>SD</given-names></name><name><surname>Cosgrove</surname><given-names>GP</given-names></name><name><surname>Brown</surname><given-names>KK</given-names></name><name><surname>Schwarz</surname><given-names>MI</given-names></name><name><surname>Schwartz</surname><given-names>DA</given-names></name><name><surname>Reynolds</surname><given-names>SD</given-names></name></person-group><article-title>The idiopathic pulmonary fibrosis honeycomb cyst contains a mucocilary pseudostratified epithelium</article-title><source>PLoS ONE</source><year>2013</year><volume>8</volume><fpage>e58658</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0058658</pub-id><?supplied-pmid 23527003?><pub-id pub-id-type="pmid">23527003</pub-id></element-citation></ref><ref id="bib-028"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heppleston</surname><given-names>AG</given-names></name></person-group><article-title>The pathology of honeycomb lung</article-title><source>Thorax</source><year>1956</year><volume>11</volume><fpage>77</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1136/thx.11.2.77</pub-id><?supplied-pmid 13337792?><pub-id pub-id-type="pmid">13337792</pub-id></element-citation></ref><ref id="bib-029"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plantier</surname><given-names>L</given-names></name><name><surname>Crestani</surname><given-names>B</given-names></name><name><surname>Wert</surname><given-names>SE</given-names></name><name><surname>Dehoux</surname><given-names>M</given-names></name><name><surname>Zweytick</surname><given-names>B</given-names></name><name><surname>Guenther</surname><given-names>A</given-names></name><name><surname>Whitsett</surname><given-names>JA</given-names></name></person-group><article-title>Ectopic respiratory epithelial cell differentiation in bronchiolised distal airspaces in idiopathic pulmonary fibrosis</article-title><source>Thorax</source><year>2011</year><volume>66</volume><fpage>651</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1136/thx.2010.151555</pub-id><?supplied-pmid 21422041?><pub-id pub-id-type="pmid">21422041</pub-id></element-citation><note><p><ext-link ext-link-type="uri" xlink:href="http://f1000.com/prime/11278956">http://f1000.com/prime/11278956</ext-link></p></note></ref><ref id="bib-030"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boucher</surname><given-names>RC</given-names></name></person-group><article-title>Idiopathic pulmonary fibrosis--a sticky business</article-title><source>N Engl J Med</source><year>2011</year><volume>364</volume><fpage>1560</fpage><lpage>1</lpage><pub-id pub-id-type="doi">10.1056/NEJMe1014191</pub-id><?supplied-pmid 21506745?><pub-id pub-id-type="pmid">21506745</pub-id></element-citation></ref><ref id="bib-031"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peljto</surname><given-names>AL</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Fingerlin</surname><given-names>TE</given-names></name><name><surname>Ma</surname><given-names>S</given-names></name><name><surname>Garcia</surname><given-names>Joe GN</given-names></name><name><surname>Richards</surname><given-names>TJ</given-names></name><name><surname>Silveira</surname><given-names>LJ</given-names></name><name><surname>Lindell</surname><given-names>KO</given-names></name><name><surname>Steele</surname><given-names>MP</given-names></name><name><surname>Loyd</surname><given-names>JE</given-names></name><name><surname>Gibson</surname><given-names>KF</given-names></name><name><surname>Seibold</surname><given-names>MA</given-names></name><name><surname>Brown</surname><given-names>KK</given-names></name><name><surname>Talbert</surname><given-names>JL</given-names></name><name><surname>Markin</surname><given-names>C</given-names></name><name><surname>Kossen</surname><given-names>K</given-names></name><name><surname>Seiwert</surname><given-names>SD</given-names></name><name><surname>Murphy</surname><given-names>E</given-names></name><name><surname>Noth</surname><given-names>I</given-names></name><name><surname>Schwarz</surname><given-names>MI</given-names></name><name><surname>Kaminski</surname><given-names>N</given-names></name><name><surname>Schwartz</surname><given-names>DA</given-names></name></person-group><article-title>Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis</article-title><source>JAMA</source><year>2013</year><volume>309</volume><fpage>2232</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1001/jama.2013.5827</pub-id><?supplied-pmid 23695349?><pub-id pub-id-type="pmid">23695349</pub-id></element-citation><note><p><ext-link ext-link-type="uri" xlink:href="http://f1000.com/prime/11278956">http://f1000.com/prime/11278956</ext-link></p></note></ref><ref id="bib-032"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ley</surname><given-names>B</given-names></name><name><surname>Collard</surname><given-names>HR</given-names></name><name><surname>King</surname><given-names>TE</given-names></name></person-group><article-title>Clinical course and prediction of survival in idiopathic pulmonary fibrosis</article-title><source>Am J Respir Crit Care Med</source><year>2011</year><volume>183</volume><fpage>431</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1164/rccm.201006-0894CI</pub-id><?supplied-pmid 20935110?><pub-id pub-id-type="pmid">20935110</pub-id></element-citation></ref><ref id="bib-033"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>DS</given-names></name><name><surname>Collard</surname><given-names>HR</given-names></name><name><surname>King</surname><given-names>TE</given-names></name></person-group><article-title>Classification and natural history of the idiopathic interstitial pneumonias</article-title><source>Proc Am Thorac Soc</source><year>2006</year><volume>3</volume><fpage>285</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1513/pats.200601-005TK</pub-id><?supplied-pmid 16738191?><pub-id pub-id-type="pmid">16738191</pub-id></element-citation></ref><ref id="bib-034"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Selman</surname><given-names>M</given-names></name><name><surname>Carrillo</surname><given-names>G</given-names></name><name><surname>Estrada</surname><given-names>A</given-names></name><name><surname>Mejia</surname><given-names>M</given-names></name><name><surname>Becerril</surname><given-names>C</given-names></name><name><surname>Cisneros</surname><given-names>J</given-names></name><name><surname>Gaxiola</surname><given-names>M</given-names></name><name><surname>P&#233;rez-Padilla</surname><given-names>R</given-names></name><name><surname>Navarro</surname><given-names>C</given-names></name><name><surname>Richards</surname><given-names>T</given-names></name><name><surname>Dauber</surname><given-names>J</given-names></name><name><surname>King</surname><given-names>TE</given-names></name><name><surname>Pardo</surname><given-names>A</given-names></name><name><surname>Kaminski</surname><given-names>N</given-names></name></person-group><article-title>Accelerated variant of idiopathic pulmonary fibrosis: clinical behavior and gene expression pattern</article-title><source>PLoS ONE</source><year>2007</year><volume>2</volume><fpage>e482</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0000482</pub-id><?supplied-pmid 17534432?><pub-id pub-id-type="pmid">17534432</pub-id></element-citation></ref><ref id="bib-035"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>IV</given-names></name><name><surname>Coldren</surname><given-names>CD</given-names></name><name><surname>Leach</surname><given-names>SM</given-names></name><name><surname>Seibold</surname><given-names>MA</given-names></name><name><surname>Murphy</surname><given-names>E</given-names></name><name><surname>Lin</surname><given-names>J</given-names></name><name><surname>Rosen</surname><given-names>R</given-names></name><name><surname>Neidermyer</surname><given-names>AJ</given-names></name><name><surname>McKean</surname><given-names>DF</given-names></name><name><surname>Groshong</surname><given-names>SD</given-names></name><name><surname>Cool</surname><given-names>C</given-names></name><name><surname>Cosgrove</surname><given-names>GP</given-names></name><name><surname>Lynch</surname><given-names>DA</given-names></name><name><surname>Brown</surname><given-names>KK</given-names></name><name><surname>Schwarz</surname><given-names>MI</given-names></name><name><surname>Fingerlin</surname><given-names>TE</given-names></name><name><surname>Schwartz</surname><given-names>DA</given-names></name></person-group><article-title>Expression of cilium-associated genes defines novel molecular subtypes of idiopathic pulmonary fibrosis</article-title><source>Thorax</source><year>2013</year><volume>68</volume><fpage>1114</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1136/thoraxjnl-2012-202943</pub-id><?supplied-pmid 23783374?><pub-id pub-id-type="pmid">23783374</pub-id></element-citation><note><p><ext-link ext-link-type="uri" xlink:href="http://f1000.com/prime/718021340">http://f1000.com/prime/718021340</ext-link></p></note></ref><ref id="bib-036"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fingerlin</surname><given-names>TE</given-names></name><name><surname>Murphy</surname><given-names>E</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Peljto</surname><given-names>AL</given-names></name><name><surname>Brown</surname><given-names>KK</given-names></name><name><surname>Steele</surname><given-names>MP</given-names></name><name><surname>Loyd</surname><given-names>JE</given-names></name><name><surname>Cosgrove</surname><given-names>GP</given-names></name><name><surname>Lynch</surname><given-names>D</given-names></name><name><surname>Groshong</surname><given-names>S</given-names></name><name><surname>Collard</surname><given-names>HR</given-names></name><name><surname>Wolters</surname><given-names>PJ</given-names></name><name><surname>Bradford</surname><given-names>WZ</given-names></name><name><surname>Kossen</surname><given-names>K</given-names></name><name><surname>Seiwert</surname><given-names>SD</given-names></name><name><surname>du Bois</surname><given-names>Roland M</given-names></name><name><surname>Garcia</surname><given-names>CK</given-names></name><name><surname>Devine</surname><given-names>MS</given-names></name><name><surname>Gudmundsson</surname><given-names>G</given-names></name><name><surname>Isaksson</surname><given-names>HJ</given-names></name><name><surname>Kaminski</surname><given-names>N</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Gibson</surname><given-names>KF</given-names></name><name><surname>Lancaster</surname><given-names>LH</given-names></name><name><surname>Cogan</surname><given-names>JD</given-names></name><name><surname>Mason</surname><given-names>WR</given-names></name><name><surname>Maher</surname><given-names>TM</given-names></name><name><surname>Molyneaux</surname><given-names>PL</given-names></name><name><surname>Wells</surname><given-names>AU</given-names></name><name><surname>Moffatt</surname><given-names>MF</given-names></name><etal/></person-group><article-title>Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis</article-title><source>Nat Genet</source><year>2013</year><volume>45</volume><fpage>613</fpage><lpage>20</lpage><?supplied-pmid 23583980?><pub-id pub-id-type="pmid">23583980</pub-id></element-citation><note><p><ext-link ext-link-type="uri" xlink:href="http://f1000.com/prime/718000223">http://f1000.com/prime/718000223</ext-link></p></note></ref><ref id="bib-037"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noth</surname><given-names>I</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Ma</surname><given-names>S</given-names></name><name><surname>Flores</surname><given-names>C</given-names></name><name><surname>Barber</surname><given-names>M</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Broderick</surname><given-names>SM</given-names></name><name><surname>Wade</surname><given-names>MS</given-names></name><name><surname>Hysi</surname><given-names>P</given-names></name><name><surname>Scuirba</surname><given-names>J</given-names></name><name><surname>Richards</surname><given-names>TJ</given-names></name><name><surname>Juan-Guardela</surname><given-names>BM</given-names></name><name><surname>Vij</surname><given-names>R</given-names></name><name><surname>Han</surname><given-names>MK</given-names></name><name><surname>Martinez</surname><given-names>FJ</given-names></name><name><surname>Kossen</surname><given-names>K</given-names></name><name><surname>Seiwert</surname><given-names>SD</given-names></name><name><surname>Christie</surname><given-names>JD</given-names></name><name><surname>Nicolae</surname><given-names>D</given-names></name><name><surname>Kaminski</surname><given-names>N</given-names></name><name><surname>Garcia</surname><given-names>Joe GN</given-names></name></person-group><article-title>Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study</article-title><source>Lancet Respir Med</source><year>2013</year><volume>1</volume><fpage>309</fpage><lpage>17</lpage><?supplied-pmid 24429156?><pub-id pub-id-type="pmid">24429156</pub-id></element-citation><note><p><ext-link ext-link-type="uri" xlink:href="http://f1000.com/prime/718246330">http://f1000.com/prime/718246330</ext-link></p></note></ref><ref id="bib-038"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zuo</surname><given-names>F</given-names></name><name><surname>Kaminski</surname><given-names>N</given-names></name><name><surname>Eugui</surname><given-names>E</given-names></name><name><surname>Allard</surname><given-names>J</given-names></name><name><surname>Yakhini</surname><given-names>Z</given-names></name><name><surname>Ben-Dor</surname><given-names>A</given-names></name><name><surname>Lollini</surname><given-names>L</given-names></name><name><surname>Morris</surname><given-names>D</given-names></name><name><surname>Kim</surname><given-names>Y</given-names></name><name><surname>DeLustro</surname><given-names>B</given-names></name><name><surname>Sheppard</surname><given-names>D</given-names></name><name><surname>Pardo</surname><given-names>A</given-names></name><name><surname>Selman</surname><given-names>M</given-names></name><name><surname>Heller</surname><given-names>RA</given-names></name></person-group><article-title>Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans</article-title><source>Proc Natl Acad Sci USA</source><year>2002</year><volume>99</volume><fpage>6292</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1073/pnas.092134099</pub-id><?supplied-pmid 11983918?><pub-id pub-id-type="pmid">11983918</pub-id></element-citation></ref><ref id="bib-039"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mura</surname><given-names>M</given-names></name><name><surname>Anraku</surname><given-names>M</given-names></name><name><surname>Yun</surname><given-names>Z</given-names></name><name><surname>McRae</surname><given-names>K</given-names></name><name><surname>Liu</surname><given-names>M</given-names></name><name><surname>Waddell</surname><given-names>TK</given-names></name><name><surname>Singer</surname><given-names>LG</given-names></name><name><surname>Granton</surname><given-names>JT</given-names></name><name><surname>Keshavjee</surname><given-names>S</given-names></name><name><surname>Perrot</surname><given-names>M de</given-names></name></person-group><article-title>Gene expression profiling in the lungs of patients with pulmonary hypertension associated with pulmonary fibrosis</article-title><source>Chest</source><year>2012</year><volume>141</volume><fpage>661</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.1378/chest.11-0449</pub-id><?supplied-pmid 21835902?><pub-id pub-id-type="pmid">21835902</pub-id></element-citation><note><p><ext-link ext-link-type="uri" xlink:href="http://f1000.com/prime/718181549">http://f1000.com/prime/718181549</ext-link></p></note></ref><ref id="bib-040"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Selman</surname><given-names>M</given-names></name><name><surname>Pardo</surname><given-names>A</given-names></name><name><surname>Barrera</surname><given-names>L</given-names></name><name><surname>Estrada</surname><given-names>A</given-names></name><name><surname>Watson</surname><given-names>SR</given-names></name><name><surname>Wilson</surname><given-names>K</given-names></name><name><surname>Aziz</surname><given-names>N</given-names></name><name><surname>Kaminski</surname><given-names>N</given-names></name><name><surname>Zlotnik</surname><given-names>A</given-names></name></person-group><article-title>Gene expression profiles distinguish idiopathic pulmonary fibrosis from hypersensitivity pneumonitis</article-title><source>Am J Respir Crit Care Med</source><year>2006</year><volume>173</volume><fpage>188</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1164/rccm.200504-644OC</pub-id><?supplied-pmid 16166619?><pub-id pub-id-type="pmid">16166619</pub-id></element-citation><note><p><ext-link ext-link-type="uri" xlink:href="http://f1000.com/prime/10145">http://f1000.com/prime/10145</ext-link></p></note></ref><ref id="bib-041"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsu</surname><given-names>E</given-names></name><name><surname>Shi</surname><given-names>H</given-names></name><name><surname>Jordan</surname><given-names>RM</given-names></name><name><surname>Lyons-Weiler</surname><given-names>J</given-names></name><name><surname>Pilewski</surname><given-names>JM</given-names></name><name><surname>Feghali-Bostwick</surname><given-names>CA</given-names></name></person-group><article-title>Lung tissues in patients with systemic sclerosis have gene expression patterns unique to pulmonary fibrosis and pulmonary hypertension</article-title><source>Arthritis Rheum</source><year>2011</year><volume>63</volume><fpage>783</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.1002/art.30159</pub-id><?supplied-pmid 21360508?><pub-id pub-id-type="pmid">21360508</pub-id></element-citation></ref><ref id="bib-042"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richards</surname><given-names>TJ</given-names></name><name><surname>Kaminski</surname><given-names>N</given-names></name><name><surname>Baribaud</surname><given-names>F</given-names></name><name><surname>Flavin</surname><given-names>S</given-names></name><name><surname>Brodmerkel</surname><given-names>C</given-names></name><name><surname>Horowitz</surname><given-names>D</given-names></name><name><surname>Li</surname><given-names>K</given-names></name><name><surname>Choi</surname><given-names>J</given-names></name><name><surname>Vuga</surname><given-names>LJ</given-names></name><name><surname>Lindell</surname><given-names>KO</given-names></name><name><surname>Klesen</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Gibson</surname><given-names>KF</given-names></name></person-group><article-title>Peripheral blood proteins predict mortality in idiopathic pulmonary fibrosis</article-title><source>Am J Respir Crit Care Med</source><year>2012</year><volume>185</volume><fpage>67</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1164/rccm.201101-0058OC</pub-id><?supplied-pmid 22016448?><pub-id pub-id-type="pmid">22016448</pub-id></element-citation><note><p><ext-link ext-link-type="uri" xlink:href="http://f1000.com/prime/13373041">http://f1000.com/prime/13373041</ext-link></p></note></ref><ref id="bib-043"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boon</surname><given-names>K</given-names></name><name><surname>Bailey</surname><given-names>NW</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Steel</surname><given-names>MP</given-names></name><name><surname>Groshong</surname><given-names>S</given-names></name><name><surname>Kervitsky</surname><given-names>D</given-names></name><name><surname>Brown</surname><given-names>KK</given-names></name><name><surname>Schwarz</surname><given-names>MI</given-names></name><name><surname>Schwartz</surname><given-names>DA</given-names></name></person-group><article-title>Molecular phenotypes distinguish patients with relatively stable from progressive idiopathic pulmonary fibrosis (IPF)</article-title><source>PLoS ONE</source><year>2009</year><volume>4</volume><fpage>e5134</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0005134</pub-id><?supplied-pmid 19347046?><pub-id pub-id-type="pmid">19347046</pub-id></element-citation><note><p><ext-link ext-link-type="uri" xlink:href="http://f1000.com/prime/718489783">http://f1000.com/prime/718489783</ext-link></p></note></ref><ref id="bib-044"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vancheri</surname><given-names>C</given-names></name></person-group><article-title>Common pathways in idiopathic pulmonary fibrosis and cancer</article-title><source>Eur Respir Rev</source><year>2013</year><volume>22</volume><fpage>265</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1183/09059180.00003613</pub-id><?supplied-pmid 23997054?><pub-id pub-id-type="pmid">23997054</pub-id></element-citation></ref><ref id="bib-045"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McAnulty</surname><given-names>RJ</given-names></name></person-group><article-title>Fibroblasts and myofibroblasts: their source, function and role in disease</article-title><source>Int J Biochem Cell Biol</source><year>2007</year><volume>39</volume><fpage>666</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1016/j.biocel.2006.11.005</pub-id><?supplied-pmid 17196874?><pub-id pub-id-type="pmid">17196874</pub-id></element-citation></ref><ref id="bib-046"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Emblom-Callahan</surname><given-names>MC</given-names></name><name><surname>Chhina</surname><given-names>MK</given-names></name><name><surname>Shlobin</surname><given-names>OA</given-names></name><name><surname>Ahmad</surname><given-names>S</given-names></name><name><surname>Reese</surname><given-names>ES</given-names></name><name><surname>Iyer</surname><given-names>Eswar PR</given-names></name><name><surname>Cox</surname><given-names>DN</given-names></name><name><surname>Brenner</surname><given-names>R</given-names></name><name><surname>Burton</surname><given-names>NA</given-names></name><name><surname>Grant</surname><given-names>GM</given-names></name><name><surname>Nathan</surname><given-names>SD</given-names></name></person-group><article-title>Genomic phenotype of non-cultured pulmonary fibroblasts in idiopathic pulmonary fibrosis</article-title><source>Genomics</source><year>2010</year><volume>96</volume><fpage>134</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1016/j.ygeno.2010.04.005</pub-id><?supplied-pmid 20451601?><pub-id pub-id-type="pmid">20451601</pub-id></element-citation></ref><ref id="bib-047"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bridges</surname><given-names>RS</given-names></name><name><surname>Kass</surname><given-names>D</given-names></name><name><surname>Loh</surname><given-names>K</given-names></name><name><surname>Glackin</surname><given-names>C</given-names></name><name><surname>Borczuk</surname><given-names>AC</given-names></name><name><surname>Greenberg</surname><given-names>S</given-names></name></person-group><article-title>Gene expression profiling of pulmonary fibrosis identifies Twist1 as an antiapoptotic molecular &#8220;rectifier&#8221; of growth factor signaling</article-title><source>Am J Pathol</source><year>2009</year><volume>175</volume><fpage>2351</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.2353/ajpath.2009.080954</pub-id><?supplied-pmid 19893041?><pub-id pub-id-type="pmid">19893041</pub-id></element-citation></ref><ref id="bib-048"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindahl</surname><given-names>GE</given-names></name><name><surname>Stock</surname><given-names>CJ</given-names></name><name><surname>Shi-Wen</surname><given-names>X</given-names></name><name><surname>Leoni</surname><given-names>P</given-names></name><name><surname>Sestini</surname><given-names>P</given-names></name><name><surname>Howat</surname><given-names>SL</given-names></name><name><surname>Bou-Gharios</surname><given-names>G</given-names></name><name><surname>Nicholson</surname><given-names>AG</given-names></name><name><surname>Denton</surname><given-names>CP</given-names></name><name><surname>Grutters</surname><given-names>JC</given-names></name><name><surname>Maher</surname><given-names>TM</given-names></name><name><surname>Wells</surname><given-names>AU</given-names></name><name><surname>Abraham</surname><given-names>DJ</given-names></name><name><surname>Renzoni</surname><given-names>EA</given-names></name></person-group><article-title>Microarray profiling reveals suppressed interferon stimulated gene program in fibroblasts from scleroderma-associated interstitial lung disease</article-title><source>Respir Res</source><year>2013</year><volume>14</volume><fpage>80</fpage><pub-id pub-id-type="doi">10.1186/1465-9921-14-80</pub-id><?supplied-pmid 23915349?><pub-id pub-id-type="pmid">23915349</pub-id></element-citation></ref><ref id="bib-049"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanders</surname><given-names>YY</given-names></name><name><surname>Ambalavanan</surname><given-names>N</given-names></name><name><surname>Halloran</surname><given-names>B</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Crossman</surname><given-names>DK</given-names></name><name><surname>Bray</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>K</given-names></name><name><surname>Thannickal</surname><given-names>VJ</given-names></name><name><surname>Hagood</surname><given-names>JS</given-names></name></person-group><article-title>Altered DNA methylation profile in idiopathic pulmonary fibrosis</article-title><source>Am J Respir Crit Care Med</source><year>2012</year><volume>186</volume><fpage>525</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1164/rccm.201201-0077OC</pub-id><?supplied-pmid 22700861?><pub-id pub-id-type="pmid">22700861</pub-id></element-citation><note><p><ext-link ext-link-type="uri" xlink:href="http://f1000.com/prime/717952703">http://f1000.com/prime/717952703</ext-link></p></note></ref><ref id="bib-050"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rabinovich</surname><given-names>EI</given-names></name><name><surname>Kapetanaki</surname><given-names>MG</given-names></name><name><surname>Steinfeld</surname><given-names>I</given-names></name><name><surname>Gibson</surname><given-names>KF</given-names></name><name><surname>Pandit</surname><given-names>KV</given-names></name><name><surname>Yu</surname><given-names>G</given-names></name><name><surname>Yakhini</surname><given-names>Z</given-names></name><name><surname>Kaminski</surname><given-names>N</given-names></name></person-group><article-title>Global methylation patterns in idiopathic pulmonary fibrosis</article-title><source>PLoS ONE</source><year>2012</year><volume>7</volume><fpage>e33770</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0033770</pub-id><?supplied-pmid 22506007?><pub-id pub-id-type="pmid">22506007</pub-id></element-citation><note><p><ext-link ext-link-type="uri" xlink:href="http://f1000.com/prime/716197983">http://f1000.com/prime/716197983</ext-link></p></note></ref><ref id="bib-051"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>SK</given-names></name><name><surname>Fisher</surname><given-names>AS</given-names></name><name><surname>Scruggs</surname><given-names>AM</given-names></name><name><surname>White</surname><given-names>ES</given-names></name><name><surname>Hogaboam</surname><given-names>CM</given-names></name><name><surname>Richardson</surname><given-names>BC</given-names></name><name><surname>Peters-Golden</surname><given-names>M</given-names></name></person-group><article-title>Hypermethylation of PTGER2 confers prostaglandin E2 resistance in fibrotic fibroblasts from humans and mice</article-title><source>Am J Pathol</source><year>2010</year><volume>177</volume><fpage>2245</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.2353/ajpath.2010.100446</pub-id><?supplied-pmid 20889571?><pub-id pub-id-type="pmid">20889571</pub-id></element-citation></ref><ref id="bib-052"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanders</surname><given-names>YY</given-names></name><name><surname>Tollefsbol</surname><given-names>TO</given-names></name><name><surname>Varisco</surname><given-names>BM</given-names></name><name><surname>Hagood</surname><given-names>JS</given-names></name></person-group><article-title>Epigenetic regulation of thy-1 by histone deacetylase inhibitor in rat lung fibroblasts</article-title><source>Am J Respir Cell Mol Biol</source><year>2011</year><volume>45</volume><fpage>16</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1165/rcmb.2010-0154OC</pub-id><?supplied-pmid 20724553?><pub-id pub-id-type="pmid">20724553</pub-id></element-citation></ref><ref id="bib-053"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coward</surname><given-names>WR</given-names></name><name><surname>Watts</surname><given-names>K</given-names></name><name><surname>Feghali-Bostwick</surname><given-names>CA</given-names></name><name><surname>Jenkins</surname><given-names>G</given-names></name><name><surname>Pang</surname><given-names>L</given-names></name></person-group><article-title>Repression of IP-10 by interactions between histone deacetylation and hypermethylation in idiopathic pulmonary fibrosis</article-title><source>Mol Cell Biol</source><year>2010</year><volume>30</volume><fpage>2874</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1128/MCB.01527-09</pub-id><?supplied-pmid 20404089?><pub-id pub-id-type="pmid">20404089</pub-id></element-citation></ref><ref id="bib-054"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oak</surname><given-names>SR</given-names></name><name><surname>Murray</surname><given-names>L</given-names></name><name><surname>Herath</surname><given-names>A</given-names></name><name><surname>Sleeman</surname><given-names>M</given-names></name><name><surname>Anderson</surname><given-names>I</given-names></name><name><surname>Joshi</surname><given-names>AD</given-names></name><name><surname>Coelho</surname><given-names>AL</given-names></name><name><surname>Flaherty</surname><given-names>KR</given-names></name><name><surname>Toews</surname><given-names>GB</given-names></name><name><surname>Knight</surname><given-names>D</given-names></name><name><surname>Martinez</surname><given-names>FJ</given-names></name><name><surname>Hogaboam</surname><given-names>CM</given-names></name></person-group><article-title>A micro RNA processing defect in rapidly progressing idiopathic pulmonary fibrosis</article-title><source>PLoS ONE</source><year>2011</year><volume>6</volume><fpage>e21253</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0021253</pub-id><?supplied-pmid 21712985?><pub-id pub-id-type="pmid">21712985</pub-id></element-citation><note><p><ext-link ext-link-type="uri" xlink:href="http://f1000.com/prime/11944957">http://f1000.com/prime/11944957</ext-link></p></note></ref><ref id="bib-055"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamada</surname><given-names>M</given-names></name><name><surname>Kubo</surname><given-names>H</given-names></name><name><surname>Ota</surname><given-names>C</given-names></name><name><surname>Takahashi</surname><given-names>T</given-names></name><name><surname>Tando</surname><given-names>Y</given-names></name><name><surname>Suzuki</surname><given-names>T</given-names></name><name><surname>Fujino</surname><given-names>N</given-names></name><name><surname>Makiguchi</surname><given-names>T</given-names></name><name><surname>Takagi</surname><given-names>K</given-names></name><name><surname>Suzuki</surname><given-names>T</given-names></name><name><surname>Ichinose</surname><given-names>M</given-names></name></person-group><article-title>The increase of microRNA-21 during lung fibrosis and its contribution to epithelial-mesenchymal transition in pulmonary epithelial cells</article-title><source>Respir Res</source><year>2013</year><volume>14</volume><fpage>95</fpage><pub-id pub-id-type="doi">10.1186/1465-9921-14-95</pub-id><?supplied-pmid 24063588?><pub-id pub-id-type="pmid">24063588</pub-id></element-citation></ref><ref id="bib-056"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lino Cardenas</surname><given-names>Christian Lacks</given-names></name><name><surname>Henaoui</surname><given-names>IS</given-names></name><name><surname>Courcot</surname><given-names>E</given-names></name><name><surname>Roderburg</surname><given-names>C</given-names></name><name><surname>Cauffiez</surname><given-names>C</given-names></name><name><surname>Aubert</surname><given-names>S</given-names></name><name><surname>Copin</surname><given-names>M</given-names></name><name><surname>Wallaert</surname><given-names>B</given-names></name><name><surname>Glowacki</surname><given-names>F</given-names></name><name><surname>Dewaeles</surname><given-names>E</given-names></name><name><surname>Milosevic</surname><given-names>J</given-names></name><name><surname>Maurizio</surname><given-names>J</given-names></name><name><surname>Tedrow</surname><given-names>J</given-names></name><name><surname>Marcet</surname><given-names>B</given-names></name><name><surname>Lo-Guidice</surname><given-names>J</given-names></name><name><surname>Kaminski</surname><given-names>N</given-names></name><name><surname>Barbry</surname><given-names>P</given-names></name><name><surname>Luedde</surname><given-names>T</given-names></name><name><surname>Perrais</surname><given-names>M</given-names></name><name><surname>Mari</surname><given-names>B</given-names></name><name><surname>Pottier</surname><given-names>N</given-names></name></person-group><article-title>miR-199a-5p Is upregulated during fibrogenic response to tissue injury and mediates TGFbeta-induced lung fibroblast activation by targeting caveolin-1</article-title><source>PLoS Genet</source><year>2013</year><volume>9</volume><fpage>e1003291</fpage><pub-id pub-id-type="doi">10.1371/journal.pgen.1003291</pub-id><?supplied-pmid 23459460?><pub-id pub-id-type="pmid">23459460</pub-id></element-citation></ref><ref id="bib-057"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>S</given-names></name><name><surname>Cui</surname><given-names>H</given-names></name><name><surname>Xie</surname><given-names>N</given-names></name><name><surname>Icyuz</surname><given-names>M</given-names></name><name><surname>Banerjee</surname><given-names>S</given-names></name><name><surname>Antony</surname><given-names>VB</given-names></name><name><surname>Abraham</surname><given-names>E</given-names></name><name><surname>Thannickal</surname><given-names>VJ</given-names></name><name><surname>Liu</surname><given-names>G</given-names></name></person-group><article-title>miR-145 regulates myofibroblast differentiation and lung fibrosis</article-title><source>FASEB J</source><year>2013</year><volume>27</volume><fpage>2382</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1096/fj.12-219493</pub-id><?supplied-pmid 23457217?><pub-id pub-id-type="pmid">23457217</pub-id></element-citation></ref><ref id="bib-058"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pandit</surname><given-names>KV</given-names></name><name><surname>Corcoran</surname><given-names>D</given-names></name><name><surname>Yousef</surname><given-names>H</given-names></name><name><surname>Yarlagadda</surname><given-names>M</given-names></name><name><surname>Tzouvelekis</surname><given-names>A</given-names></name><name><surname>Gibson</surname><given-names>KF</given-names></name><name><surname>Konishi</surname><given-names>K</given-names></name><name><surname>Yousem</surname><given-names>SA</given-names></name><name><surname>Singh</surname><given-names>M</given-names></name><name><surname>Handley</surname><given-names>D</given-names></name><name><surname>Richards</surname><given-names>T</given-names></name><name><surname>Selman</surname><given-names>M</given-names></name><name><surname>Watkins</surname><given-names>SC</given-names></name><name><surname>Pardo</surname><given-names>A</given-names></name><name><surname>Ben-Yehudah</surname><given-names>A</given-names></name><name><surname>Bouros</surname><given-names>D</given-names></name><name><surname>Eickelberg</surname><given-names>O</given-names></name><name><surname>Ray</surname><given-names>P</given-names></name><name><surname>Benos</surname><given-names>PV</given-names></name><name><surname>Kaminski</surname><given-names>N</given-names></name></person-group><article-title>Inhibition and role of let-7d in idiopathic pulmonary fibrosis</article-title><source>Am J Respir Crit Care Med</source><year>2010</year><volume>182</volume><fpage>220</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1164/rccm.200911-1698OC</pub-id><?supplied-pmid 20395557?><pub-id pub-id-type="pmid">20395557</pub-id></element-citation></ref><ref id="bib-059"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dakhlallah</surname><given-names>D</given-names></name><name><surname>Batte</surname><given-names>K</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Cantemir-Stone</surname><given-names>CZ</given-names></name><name><surname>Yan</surname><given-names>P</given-names></name><name><surname>Nuovo</surname><given-names>G</given-names></name><name><surname>Mikhail</surname><given-names>A</given-names></name><name><surname>Hitchcock</surname><given-names>CL</given-names></name><name><surname>Wright</surname><given-names>VP</given-names></name><name><surname>Nana-Sinkam</surname><given-names>SP</given-names></name><name><surname>Piper</surname><given-names>MG</given-names></name><name><surname>Marsh</surname><given-names>CB</given-names></name></person-group><article-title>Epigenetic regulation of miR-17~92 contributes to the pathogenesis of pulmonary fibrosis</article-title><source>Am J Respir Crit Care Med</source><year>2013</year><volume>187</volume><fpage>397</fpage><lpage>405</lpage><pub-id pub-id-type="doi">10.1164/rccm.201205-0888OC</pub-id><?supplied-pmid 23306545?><pub-id pub-id-type="pmid">23306545</pub-id></element-citation></ref><ref id="bib-060"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pandit</surname><given-names>KV</given-names></name><name><surname>Milosevic</surname><given-names>J</given-names></name><name><surname>Kaminski</surname><given-names>N</given-names></name></person-group><article-title>MicroRNAs in idiopathic pulmonary fibrosis</article-title><source>Transl Res</source><year>2011</year><volume>157</volume><fpage>191</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/j.trsl.2011.01.012</pub-id><?supplied-pmid 21420029?><pub-id pub-id-type="pmid">21420029</pub-id></element-citation></ref><ref id="bib-061"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hogaboam</surname><given-names>CM</given-names></name><name><surname>Murray</surname><given-names>L</given-names></name><name><surname>Martinez</surname><given-names>FJ</given-names></name></person-group><article-title>Epigenetic mechanisms through which Toll-like receptor-9 drives idiopathic pulmonary fibrosis progression</article-title><source>Proc Am Thorac Soc</source><year>2012</year><volume>9</volume><fpage>172</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1513/pats.201201-002AW</pub-id><?supplied-pmid 22802293?><pub-id pub-id-type="pmid">22802293</pub-id></element-citation></ref><ref id="bib-062"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raghu</surname><given-names>G</given-names></name><name><surname>Anstrom</surname><given-names>KJ</given-names></name><name><surname>King</surname><given-names>TE</given-names></name><name><surname>Lasky</surname><given-names>JA</given-names></name><name><surname>Martinez</surname><given-names>FJ</given-names></name></person-group><article-title>Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis</article-title><source>N Engl J Med</source><year>2012</year><volume>366</volume><fpage>1968</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1113354</pub-id><?supplied-pmid 22607134?><pub-id pub-id-type="pmid">22607134</pub-id></element-citation><note><p><ext-link ext-link-type="uri" xlink:href="http://f1000.com/prime/716097808">http://f1000.com/prime/716097808</ext-link></p></note></ref><ref id="bib-063"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mantovani</surname><given-names>A</given-names></name><name><surname>Sozzani</surname><given-names>S</given-names></name><name><surname>Locati</surname><given-names>M</given-names></name><name><surname>Allavena</surname><given-names>P</given-names></name><name><surname>Sica</surname><given-names>A</given-names></name></person-group><article-title>Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes</article-title><source>Trends Immunol</source><year>2002</year><volume>23</volume><fpage>549</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1016/S1471-4906(02)02302-5</pub-id><?supplied-pmid 12401408?><pub-id pub-id-type="pmid">12401408</pub-id></element-citation></ref><ref id="bib-064"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prasse</surname><given-names>A</given-names></name><name><surname>Probst</surname><given-names>C</given-names></name><name><surname>Bargagli</surname><given-names>E</given-names></name><name><surname>Zissel</surname><given-names>G</given-names></name><name><surname>Toews</surname><given-names>GB</given-names></name><name><surname>Flaherty</surname><given-names>KR</given-names></name><name><surname>Olschewski</surname><given-names>M</given-names></name><name><surname>Rottoli</surname><given-names>P</given-names></name><name><surname>M&#252;ller-Quernheim</surname><given-names>J</given-names></name></person-group><article-title>Serum CC-chemokine ligand 18 concentration predicts outcome in idiopathic pulmonary fibrosis</article-title><source>Am J Respir Crit Care Med</source><year>2009</year><volume>179</volume><fpage>717</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1164/rccm.200808-1201OC</pub-id><?supplied-pmid 19179488?><pub-id pub-id-type="pmid">19179488</pub-id></element-citation><note><p><ext-link ext-link-type="uri" xlink:href="http://f1000.com/prime/1161000">http://f1000.com/prime/1161000</ext-link></p></note></ref><ref id="bib-065"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tiev</surname><given-names>KP</given-names></name><name><surname>Hua-Huy</surname><given-names>T</given-names></name><name><surname>Kettaneh</surname><given-names>A</given-names></name><name><surname>Gain</surname><given-names>M</given-names></name><name><surname>Duong-Quy</surname><given-names>S</given-names></name><name><surname>Tol&#233;dano</surname><given-names>C</given-names></name><name><surname>Cabane</surname><given-names>J</given-names></name><name><surname>Dinh-Xuan</surname><given-names>AT</given-names></name></person-group><article-title>Serum CC chemokine ligand-18 predicts lung disease worsening in systemic sclerosis</article-title><source>Eur Respir J</source><year>2011</year><volume>38</volume><fpage>1355</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1183/09031936.00004711</pub-id><?supplied-pmid 21778167?><pub-id pub-id-type="pmid">21778167</pub-id></element-citation><note><p><ext-link ext-link-type="uri" xlink:href="http://f1000.com/prime/718489784">http://f1000.com/prime/718489784</ext-link></p></note></ref><ref id="bib-066"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huebener</surname><given-names>P</given-names></name><name><surname>Schwabe</surname><given-names>RF</given-names></name></person-group><article-title>Regulation of wound healing and organ fibrosis by toll-like receptors</article-title><source>Biochim Biophys Acta</source><year>2013</year><volume>1832</volume><fpage>1005</fpage><lpage>17</lpage><?supplied-pmid 23220258?><pub-id pub-id-type="pmid">23220258</pub-id></element-citation></ref><ref id="bib-067"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawai</surname><given-names>T</given-names></name><name><surname>Akira</surname><given-names>S</given-names></name></person-group><article-title>The roles of TLRs, RLRs and NLRs in pathogen recognition</article-title><source>Int Immunol</source><year>2009</year><volume>21</volume><fpage>317</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1093/intimm/dxp017</pub-id><?supplied-pmid 19246554?><pub-id pub-id-type="pmid">19246554</pub-id></element-citation></ref><ref id="bib-068"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scheibner</surname><given-names>KA</given-names></name><name><surname>Lutz</surname><given-names>MA</given-names></name><name><surname>Boodoo</surname><given-names>S</given-names></name><name><surname>Fenton</surname><given-names>MJ</given-names></name><name><surname>Powell</surname><given-names>JD</given-names></name><name><surname>Horton</surname><given-names>MR</given-names></name></person-group><article-title>Hyaluronan fragments act as an endogenous danger signal by engaging TLR2</article-title><source>J Immunol</source><year>2006</year><volume>177</volume><fpage>1272</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.177.2.1272</pub-id><?supplied-pmid 16818787?><pub-id pub-id-type="pmid">16818787</pub-id></element-citation></ref><ref id="bib-069"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Millien</surname><given-names>VO</given-names></name><name><surname>Lu</surname><given-names>W</given-names></name><name><surname>Shaw</surname><given-names>J</given-names></name><name><surname>Yuan</surname><given-names>X</given-names></name><name><surname>Mak</surname><given-names>G</given-names></name><name><surname>Roberts</surname><given-names>L</given-names></name><name><surname>Song</surname><given-names>L</given-names></name><name><surname>Knight</surname><given-names>JM</given-names></name><name><surname>Creighton</surname><given-names>CJ</given-names></name><name><surname>Luong</surname><given-names>A</given-names></name><name><surname>Kheradmand</surname><given-names>F</given-names></name><name><surname>Corry</surname><given-names>DB</given-names></name></person-group><article-title>Cleavage of fibrinogen by proteinases elicits allergic responses through Toll-like receptor 4</article-title><source>Science</source><year>2013</year><volume>341</volume><fpage>792</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1126/science.1240342</pub-id><?supplied-pmid 23950537?><pub-id pub-id-type="pmid">23950537</pub-id></element-citation><note><p><ext-link ext-link-type="uri" xlink:href="http://f1000.com/prime/718078457">http://f1000.com/prime/718078457</ext-link></p></note></ref><ref id="bib-070"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meneghin</surname><given-names>A</given-names></name><name><surname>Choi</surname><given-names>ES</given-names></name><name><surname>Evanoff</surname><given-names>HL</given-names></name><name><surname>Kunkel</surname><given-names>SL</given-names></name><name><surname>Martinez</surname><given-names>FJ</given-names></name><name><surname>Flaherty</surname><given-names>KR</given-names></name><name><surname>Toews</surname><given-names>GB</given-names></name><name><surname>Hogaboam</surname><given-names>CM</given-names></name></person-group><article-title>TLR9 is expressed in idiopathic interstitial pneumonia and its activation promotes in vitro myofibroblast differentiation</article-title><source>Histochem Cell Biol</source><year>2008</year><volume>130</volume><fpage>979</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1007/s00418-008-0466-z</pub-id><?supplied-pmid 18633634?><pub-id pub-id-type="pmid">18633634</pub-id></element-citation><note><p><ext-link ext-link-type="uri" xlink:href="http://f1000.com/prime/718489785">http://f1000.com/prime/718489785</ext-link></p></note></ref><ref id="bib-071"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Margaritopoulos</surname><given-names>GA</given-names></name><name><surname>Antoniou</surname><given-names>KM</given-names></name><name><surname>Karagiannis</surname><given-names>K</given-names></name><name><surname>Samara</surname><given-names>KD</given-names></name><name><surname>Lasithiotaki</surname><given-names>I</given-names></name><name><surname>Vassalou</surname><given-names>E</given-names></name><name><surname>Lymbouridou</surname><given-names>R</given-names></name><name><surname>Koutala</surname><given-names>H</given-names></name><name><surname>Siafakas</surname><given-names>NM</given-names></name></person-group><article-title>Investigation of Toll-like receptors in the pathogenesis of fibrotic and granulomatous disorders: a bronchoalveolar lavage study</article-title><source>Fibrogenesis Tissue Repair</source><year>2010</year><volume>3</volume><fpage>20</fpage><?supplied-pmid 20937083?><pub-id pub-id-type="pmid">20937083</pub-id></element-citation><note><p><ext-link ext-link-type="uri" xlink:href="http://f1000.com/prime/718489786">http://f1000.com/prime/718489786</ext-link></p></note></ref><ref id="bib-072"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hogaboam</surname><given-names>CM</given-names></name><name><surname>Trujillo</surname><given-names>G</given-names></name><name><surname>Martinez</surname><given-names>FJ</given-names></name></person-group><article-title>Aberrant innate immune sensing leads to the rapid progression of idiopathic pulmonary fibrosis</article-title><source>Fibrogenesis Tissue Repair</source><year>2012</year><volume>5</volume><issue>Suppl 1</issue><fpage>S3</fpage><?supplied-pmid 23259678?><pub-id pub-id-type="pmid">23259678</pub-id></element-citation><note><p><ext-link ext-link-type="uri" xlink:href="http://f1000.com/prime/718489787">http://f1000.com/prime/718489787</ext-link></p></note></ref><ref id="bib-073"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trujillo</surname><given-names>G</given-names></name><name><surname>Meneghin</surname><given-names>A</given-names></name><name><surname>Flaherty</surname><given-names>KR</given-names></name><name><surname>Sholl</surname><given-names>LM</given-names></name><name><surname>Myers</surname><given-names>JL</given-names></name><name><surname>Kazerooni</surname><given-names>EA</given-names></name><name><surname>Gross</surname><given-names>BH</given-names></name><name><surname>Oak</surname><given-names>SR</given-names></name><name><surname>Coelho</surname><given-names>AL</given-names></name><name><surname>Evanoff</surname><given-names>H</given-names></name><name><surname>Day</surname><given-names>E</given-names></name><name><surname>Toews</surname><given-names>GB</given-names></name><name><surname>Joshi</surname><given-names>AD</given-names></name><name><surname>Schaller</surname><given-names>MA</given-names></name><name><surname>Waters</surname><given-names>B</given-names></name><name><surname>Jarai</surname><given-names>G</given-names></name><name><surname>Westwick</surname><given-names>J</given-names></name><name><surname>Kunkel</surname><given-names>SL</given-names></name><name><surname>Martinez</surname><given-names>FJ</given-names></name><name><surname>Hogaboam</surname><given-names>CM</given-names></name></person-group><article-title>TLR9 differentiates rapidly from slowly progressing forms of idiopathic pulmonary fibrosis</article-title><source>Sci Transl Med</source><year>2010</year><volume>2</volume><fpage>57ra82</fpage><pub-id pub-id-type="doi">10.1126/scitranslmed.3001510</pub-id><?supplied-pmid 21068441?><pub-id pub-id-type="pmid">21068441</pub-id></element-citation><note><p><ext-link ext-link-type="uri" xlink:href="http://f1000.com/prime/718489788">http://f1000.com/prime/718489788</ext-link></p></note></ref><ref id="bib-074"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cavassani</surname><given-names>KA</given-names></name><name><surname>Ishii</surname><given-names>M</given-names></name><name><surname>Wen</surname><given-names>H</given-names></name><name><surname>Schaller</surname><given-names>MA</given-names></name><name><surname>Lincoln</surname><given-names>PM</given-names></name><name><surname>Lukacs</surname><given-names>NW</given-names></name><name><surname>Hogaboam</surname><given-names>CM</given-names></name><name><surname>Kunkel</surname><given-names>SL</given-names></name></person-group><article-title>TLR3 is an endogenous sensor of tissue necrosis during acute inflammatory events</article-title><source>J Exp Med</source><year>2008</year><volume>205</volume><fpage>2609</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1084/jem.20081370</pub-id><?supplied-pmid 18838547?><pub-id pub-id-type="pmid">18838547</pub-id></element-citation><note><p><ext-link ext-link-type="uri" xlink:href="http://f1000.com/prime/1124517">http://f1000.com/prime/1124517</ext-link></p></note></ref><ref id="bib-075"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawai</surname><given-names>T</given-names></name><name><surname>Akira</surname><given-names>S</given-names></name></person-group><article-title>The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors</article-title><source>Nat Immunol</source><year>2010</year><volume>11</volume><fpage>373</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.1038/ni.1863</pub-id><?supplied-pmid 20404851?><pub-id pub-id-type="pmid">20404851</pub-id></element-citation></ref><ref id="bib-076"><label>76</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Dwyer</surname><given-names>DN</given-names></name><name><surname>Armstrong</surname><given-names>ME</given-names></name><name><surname>Trujillo</surname><given-names>G</given-names></name><name><surname>Cooke</surname><given-names>G</given-names></name><name><surname>Keane</surname><given-names>MP</given-names></name><name><surname>Fallon</surname><given-names>PG</given-names></name><name><surname>Simpson</surname><given-names>AJ</given-names></name><name><surname>Millar</surname><given-names>AB</given-names></name><name><surname>McGrath</surname><given-names>EE</given-names></name><name><surname>Whyte</surname><given-names>MK</given-names></name><name><surname>Hirani</surname><given-names>N</given-names></name><name><surname>Hogaboam</surname><given-names>CM</given-names></name><name><surname>Donnelly</surname><given-names>SC</given-names></name></person-group><article-title>The Toll-like receptor 3 L412F polymorphism and disease progression in idiopathic pulmonary fibrosis</article-title><source>Am J Respir Crit Care Med</source><year>2013</year><volume>188</volume><fpage>1442</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1164/rccm.201304-0760OC</pub-id><?supplied-pmid 24070541?><pub-id pub-id-type="pmid">24070541</pub-id></element-citation><note><p><ext-link ext-link-type="uri" xlink:href="http://f1000.com/prime/718121848">http://f1000.com/prime/718121848</ext-link></p></note></ref><ref id="bib-077"><label>77</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noth</surname><given-names>I</given-names></name><name><surname>Kaminski</surname><given-names>N</given-names></name></person-group><article-title>Idiopathic pulmonary fibrosis: time to get personal?</article-title><source>Am J Respir Crit Care Med</source><year>2013</year><volume>188</volume><fpage>1392</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1164/rccm.201311-1956ED</pub-id><?supplied-pmid 24328772?><pub-id pub-id-type="pmid">24328772</pub-id></element-citation></ref><ref id="bib-078"><label>78</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fink</surname><given-names>JN</given-names></name><name><surname>Ortega</surname><given-names>HG</given-names></name><name><surname>Reynolds</surname><given-names>HY</given-names></name><name><surname>Cormier</surname><given-names>YF</given-names></name><name><surname>Fan</surname><given-names>LL</given-names></name><name><surname>Franks</surname><given-names>TJ</given-names></name><name><surname>Kreiss</surname><given-names>K</given-names></name><name><surname>Kunkel</surname><given-names>S</given-names></name><name><surname>Lynch</surname><given-names>D</given-names></name><name><surname>Quirce</surname><given-names>S</given-names></name><name><surname>Rose</surname><given-names>C</given-names></name><name><surname>Schleimer</surname><given-names>RP</given-names></name><name><surname>Schuyler</surname><given-names>MR</given-names></name><name><surname>Selman</surname><given-names>M</given-names></name><name><surname>Trout</surname><given-names>D</given-names></name><name><surname>Yoshizawa</surname><given-names>Y</given-names></name></person-group><article-title>Needs and opportunities for research in hypersensitivity pneumonitis</article-title><source>Am J Respir Crit Care Med</source><year>2005</year><volume>171</volume><fpage>792</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1164/rccm.200409-1205WS</pub-id><?supplied-pmid 15657460?><pub-id pub-id-type="pmid">15657460</pub-id></element-citation></ref><ref id="bib-079"><label>79</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takemura</surname><given-names>T</given-names></name><name><surname>Akashi</surname><given-names>T</given-names></name><name><surname>Kamiya</surname><given-names>H</given-names></name><name><surname>Ikushima</surname><given-names>S</given-names></name><name><surname>Ando</surname><given-names>T</given-names></name><name><surname>Oritsu</surname><given-names>M</given-names></name><name><surname>Sawahata</surname><given-names>M</given-names></name><name><surname>Ogura</surname><given-names>T</given-names></name></person-group><article-title>Pathological differentiation of chronic hypersensitivity pneumonitis from idiopathic pulmonary fibrosis/usual interstitial pneumonia</article-title><source>Histopathology</source><year>2012</year><volume>61</volume><fpage>1026</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2559.2012.04322.x</pub-id><?supplied-pmid 22882269?><pub-id pub-id-type="pmid">22882269</pub-id></element-citation></ref><ref id="bib-080"><label>80</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gilani</surname><given-names>SR</given-names></name><name><surname>Vuga</surname><given-names>LJ</given-names></name><name><surname>Lindell</surname><given-names>KO</given-names></name><name><surname>Gibson</surname><given-names>KF</given-names></name><name><surname>Xue</surname><given-names>J</given-names></name><name><surname>Kaminski</surname><given-names>N</given-names></name><name><surname>Valentine</surname><given-names>VG</given-names></name><name><surname>Lindsay</surname><given-names>EK</given-names></name><name><surname>George</surname><given-names>MP</given-names></name><name><surname>Steele</surname><given-names>C</given-names></name><name><surname>Duncan</surname><given-names>SR</given-names></name></person-group><article-title>CD28 down-regulation on circulating CD4 T-cells is associated with poor prognoses of patients with idiopathic pulmonary fibrosis</article-title><source>PLoS ONE</source><year>2010</year><volume>5</volume><fpage>e8959</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0008959</pub-id><?supplied-pmid 20126467?><pub-id pub-id-type="pmid">20126467</pub-id></element-citation><note><p><ext-link ext-link-type="uri" xlink:href="http://f1000.com/prime/718489789">http://f1000.com/prime/718489789</ext-link></p></note></ref><ref id="bib-081"><label>81</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moro-Garc&#237;a</surname><given-names>MA</given-names></name><name><surname>Alonso-Arias</surname><given-names>R</given-names></name><name><surname>L&#243;pez-Larrea</surname><given-names>C</given-names></name></person-group><article-title>Molecular mechanisms involved in the aging of the T-cell immune response</article-title><source>Curr Genomics</source><year>2012</year><volume>13</volume><fpage>589</fpage><lpage>602</lpage><pub-id pub-id-type="doi">10.2174/138920212803759749</pub-id><?supplied-pmid 23730199?><pub-id pub-id-type="pmid">23730199</pub-id></element-citation></ref><ref id="bib-082"><label>82</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herazo-Maya</surname><given-names>JD</given-names></name><name><surname>Noth</surname><given-names>I</given-names></name><name><surname>Duncan</surname><given-names>SR</given-names></name><name><surname>Kim</surname><given-names>S</given-names></name><name><surname>Ma</surname><given-names>S</given-names></name><name><surname>Tseng</surname><given-names>GC</given-names></name><name><surname>Feingold</surname><given-names>E</given-names></name><name><surname>Juan-Guardela</surname><given-names>BM</given-names></name><name><surname>Richards</surname><given-names>TJ</given-names></name><name><surname>Lussier</surname><given-names>Y</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Vij</surname><given-names>R</given-names></name><name><surname>Lindell</surname><given-names>KO</given-names></name><name><surname>Xue</surname><given-names>J</given-names></name><name><surname>Gibson</surname><given-names>KF</given-names></name><name><surname>Shapiro</surname><given-names>SD</given-names></name><name><surname>Garcia</surname><given-names>Joe GN</given-names></name><name><surname>Kaminski</surname><given-names>N</given-names></name></person-group><article-title>Peripheral blood mononuclear cell gene expression profiles predict poor outcome in idiopathic pulmonary fibrosis</article-title><source>Sci Transl Med</source><year>2013</year><volume>5</volume><fpage>205ra136</fpage><?supplied-pmid 24089408?><pub-id pub-id-type="pmid">24089408</pub-id></element-citation><note><p><ext-link ext-link-type="uri" xlink:href="http://f1000.com/prime/718131173">http://f1000.com/prime/718131173</ext-link></p></note></ref><ref id="bib-083"><label>83</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosas</surname><given-names>IO</given-names></name><name><surname>Ren</surname><given-names>P</given-names></name><name><surname>Avila</surname><given-names>NA</given-names></name><name><surname>Chow</surname><given-names>CK</given-names></name><name><surname>Franks</surname><given-names>TJ</given-names></name><name><surname>Travis</surname><given-names>WD</given-names></name><name><surname>McCoy</surname><given-names>JP</given-names></name><name><surname>May</surname><given-names>RM</given-names></name><name><surname>Wu</surname><given-names>H</given-names></name><name><surname>Nguyen</surname><given-names>DM</given-names></name><name><surname>Arcos-Burgos</surname><given-names>M</given-names></name><name><surname>MacDonald</surname><given-names>SD</given-names></name><name><surname>Gochuico</surname><given-names>BR</given-names></name></person-group><article-title>Early interstitial lung disease in familial pulmonary fibrosis</article-title><source>Am J Respir Crit Care Med</source><year>2007</year><volume>176</volume><fpage>698</fpage><lpage>705</lpage><pub-id pub-id-type="doi">10.1164/rccm.200702-254OC</pub-id><?supplied-pmid 17641157?><pub-id pub-id-type="pmid">17641157</pub-id></element-citation><note><p><ext-link ext-link-type="uri" xlink:href="http://f1000.com/prime/1090921">http://f1000.com/prime/1090921</ext-link></p></note></ref><ref id="bib-084"><label>84</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marchal-Somm&#233;</surname><given-names>J</given-names></name><name><surname>Uzunhan</surname><given-names>Y</given-names></name><name><surname>Marchand-Adam</surname><given-names>S</given-names></name><name><surname>Kambouchner</surname><given-names>M</given-names></name><name><surname>Valeyre</surname><given-names>D</given-names></name><name><surname>Crestani</surname><given-names>B</given-names></name><name><surname>Soler</surname><given-names>P</given-names></name></person-group><article-title>Dendritic cells accumulate in human fibrotic interstitial lung disease</article-title><source>Am J Respir Crit Care Med</source><year>2007</year><volume>176</volume><fpage>1007</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1164/rccm.200609-1347OC</pub-id><?supplied-pmid 17717200?><pub-id pub-id-type="pmid">17717200</pub-id></element-citation></ref><ref id="bib-085"><label>85</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daniil</surname><given-names>Z</given-names></name><name><surname>Kitsanta</surname><given-names>P</given-names></name><name><surname>Kapotsis</surname><given-names>G</given-names></name><name><surname>Mathioudaki</surname><given-names>M</given-names></name><name><surname>Kollintza</surname><given-names>A</given-names></name><name><surname>Karatza</surname><given-names>M</given-names></name><name><surname>Milic-Emili</surname><given-names>J</given-names></name><name><surname>Roussos</surname><given-names>C</given-names></name><name><surname>Papiris</surname><given-names>SA</given-names></name></person-group><article-title>CD8+ T lymphocytes in lung tissue from patients with idiopathic pulmonary fibrosis</article-title><source>Respir Res</source><year>2005</year><volume>6</volume><fpage>81</fpage><pub-id pub-id-type="doi">10.1186/1465-9921-6-81</pub-id><?supplied-pmid 16042790?><pub-id pub-id-type="pmid">16042790</pub-id></element-citation></ref><ref id="bib-086"><label>86</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feghali-Bostwick</surname><given-names>CA</given-names></name><name><surname>Tsai</surname><given-names>CG</given-names></name><name><surname>Valentine</surname><given-names>VG</given-names></name><name><surname>Kantrow</surname><given-names>S</given-names></name><name><surname>Stoner</surname><given-names>MW</given-names></name><name><surname>Pilewski</surname><given-names>JM</given-names></name><name><surname>Gadgil</surname><given-names>A</given-names></name><name><surname>George</surname><given-names>MP</given-names></name><name><surname>Gibson</surname><given-names>KF</given-names></name><name><surname>Choi</surname><given-names>Augustine MK</given-names></name><name><surname>Kaminski</surname><given-names>N</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Duncan</surname><given-names>SR</given-names></name></person-group><article-title>Cellular and humoral autoreactivity in idiopathic pulmonary fibrosis</article-title><source>J Immunol</source><year>2007</year><volume>179</volume><fpage>2592</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.179.4.2592</pub-id><?supplied-pmid 17675522?><pub-id pub-id-type="pmid">17675522</pub-id></element-citation><note><p><ext-link ext-link-type="uri" xlink:href="http://f1000.com/prime/718489790">http://f1000.com/prime/718489790</ext-link></p></note></ref><ref id="bib-087"><label>87</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reilkoff</surname><given-names>RA</given-names></name><name><surname>Peng</surname><given-names>H</given-names></name><name><surname>Murray</surname><given-names>LA</given-names></name><name><surname>Peng</surname><given-names>X</given-names></name><name><surname>Russell</surname><given-names>T</given-names></name><name><surname>Montgomery</surname><given-names>R</given-names></name><name><surname>Feghali-Bostwick</surname><given-names>C</given-names></name><name><surname>Shaw</surname><given-names>A</given-names></name><name><surname>Homer</surname><given-names>RJ</given-names></name><name><surname>Gulati</surname><given-names>M</given-names></name><name><surname>Mathur</surname><given-names>A</given-names></name><name><surname>Elias</surname><given-names>JA</given-names></name><name><surname>Herzog</surname><given-names>EL</given-names></name></person-group><article-title>Semaphorin 7a+ regulatory T cells are associated with progressive idiopathic pulmonary fibrosis and are implicated in transforming growth factor-&#946;1-induced pulmonary fibrosis</article-title><source>Am J Respir Crit Care Med</source><year>2013</year><volume>187</volume><fpage>180</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1164/rccm.201206-1109OC</pub-id><?supplied-pmid 23220917?><pub-id pub-id-type="pmid">23220917</pub-id></element-citation><note><p><ext-link ext-link-type="uri" xlink:href="http://f1000.com/prime/717971657">http://f1000.com/prime/717971657</ext-link></p></note></ref><ref id="bib-088"><label>88</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kahloon</surname><given-names>RA</given-names></name><name><surname>Xue</surname><given-names>J</given-names></name><name><surname>Bhargava</surname><given-names>A</given-names></name><name><surname>Csizmadia</surname><given-names>E</given-names></name><name><surname>Otterbein</surname><given-names>L</given-names></name><name><surname>Kass</surname><given-names>DJ</given-names></name><name><surname>Bon</surname><given-names>J</given-names></name><name><surname>Soejima</surname><given-names>M</given-names></name><name><surname>Levesque</surname><given-names>MC</given-names></name><name><surname>Lindell</surname><given-names>KO</given-names></name><name><surname>Gibson</surname><given-names>KF</given-names></name><name><surname>Kaminski</surname><given-names>N</given-names></name><name><surname>Banga</surname><given-names>G</given-names></name><name><surname>Oddis</surname><given-names>CV</given-names></name><name><surname>Pilewski</surname><given-names>JM</given-names></name><name><surname>Sciurba</surname><given-names>FC</given-names></name><name><surname>Donahoe</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Duncan</surname><given-names>SR</given-names></name></person-group><article-title>Patients with idiopathic pulmonary fibrosis with antibodies to heat shock protein 70 have poor prognoses</article-title><source>Am J Respir Crit Care Med</source><year>2013</year><volume>187</volume><fpage>768</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.1164/rccm.201203-0506OC</pub-id><?supplied-pmid 23262513?><pub-id pub-id-type="pmid">23262513</pub-id></element-citation><note><p><ext-link ext-link-type="uri" xlink:href="http://f1000.com/prime/717973243">http://f1000.com/prime/717973243</ext-link></p></note></ref><ref id="bib-089"><label>89</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marchal-Somm&#233;</surname><given-names>J</given-names></name><name><surname>Uzunhan</surname><given-names>Y</given-names></name><name><surname>Marchand-Adam</surname><given-names>S</given-names></name><name><surname>Valeyre</surname><given-names>D</given-names></name><name><surname>Soumelis</surname><given-names>V</given-names></name><name><surname>Crestani</surname><given-names>B</given-names></name><name><surname>Soler</surname><given-names>P</given-names></name></person-group><article-title>Cutting edge: nonproliferating mature immune cells form a novel type of organized lymphoid structure in idiopathic pulmonary fibrosis</article-title><source>J Immunol</source><year>2006</year><volume>176</volume><fpage>5735</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.176.10.5735</pub-id><?supplied-pmid 16670278?><pub-id pub-id-type="pmid">16670278</pub-id></element-citation><note><p><ext-link ext-link-type="uri" xlink:href="http://f1000.com/prime/14151">http://f1000.com/prime/14151</ext-link></p></note></ref><ref id="bib-090"><label>90</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xue</surname><given-names>J</given-names></name><name><surname>Kass</surname><given-names>DJ</given-names></name><name><surname>Bon</surname><given-names>J</given-names></name><name><surname>Vuga</surname><given-names>L</given-names></name><name><surname>Tan</surname><given-names>J</given-names></name><name><surname>Csizmadia</surname><given-names>E</given-names></name><name><surname>Otterbein</surname><given-names>L</given-names></name><name><surname>Soejima</surname><given-names>M</given-names></name><name><surname>Levesque</surname><given-names>MC</given-names></name><name><surname>Gibson</surname><given-names>KF</given-names></name><name><surname>Kaminski</surname><given-names>N</given-names></name><name><surname>Pilewski</surname><given-names>JM</given-names></name><name><surname>Donahoe</surname><given-names>M</given-names></name><name><surname>Sciurba</surname><given-names>FC</given-names></name><name><surname>Duncan</surname><given-names>SR</given-names></name></person-group><article-title>Plasma B lymphocyte stimulator and B cell differentiation in idiopathic pulmonary fibrosis patients</article-title><source>J Immunol</source><year>2013</year><volume>191</volume><fpage>2089</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1203476</pub-id><?supplied-pmid 23872052?><pub-id pub-id-type="pmid">23872052</pub-id></element-citation><note><p><ext-link ext-link-type="uri" xlink:href="http://f1000.com/prime/718043484">http://f1000.com/prime/718043484</ext-link></p></note></ref><ref id="bib-091"><label>91</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Campbell</surname><given-names>DA</given-names></name><name><surname>Poulter</surname><given-names>LW</given-names></name><name><surname>Janossy</surname><given-names>G</given-names></name><name><surname>du Bois</surname><given-names>RM</given-names></name></person-group><article-title>Immunohistological analysis of lung tissue from patients with cryptogenic fibrosing alveolitis suggesting local expression of immune hypersensitivity</article-title><source>Thorax</source><year>1985</year><volume>40</volume><fpage>405</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1136/thx.40.6.405</pub-id><?supplied-pmid 3875162?><pub-id pub-id-type="pmid">3875162</pub-id></element-citation></ref><ref id="bib-092"><label>92</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Browning</surname><given-names>JL</given-names></name></person-group><article-title>B cells move to centre stage: novel opportunities for autoimmune disease treatment</article-title><source>Nat Rev Drug Discov</source><year>2006</year><volume>5</volume><fpage>564</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1038/nrd2085</pub-id><?supplied-pmid 16816838?><pub-id pub-id-type="pmid">16816838</pub-id></element-citation></ref><ref id="bib-093"><label>93</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vuga</surname><given-names>LJ</given-names></name><name><surname>Tedrow</surname><given-names>JR</given-names></name><name><surname>Pandit</surname><given-names>KV</given-names></name><name><surname>Tan</surname><given-names>J</given-names></name><name><surname>Kass</surname><given-names>DJ</given-names></name><name><surname>Xue</surname><given-names>J</given-names></name><name><surname>Chandra</surname><given-names>D</given-names></name><name><surname>Leader</surname><given-names>JK</given-names></name><name><surname>Gibson</surname><given-names>KF</given-names></name><name><surname>Kaminski</surname><given-names>N</given-names></name><name><surname>Sciurba</surname><given-names>FC</given-names></name><name><surname>Duncan</surname><given-names>SR</given-names></name></person-group><article-title>C-X-C Motif Chemokine 13 (CXCL13) Is a Prognostic Biomarker of Idiopathic Pulmonary Fibrosis</article-title><source>Am J Respir Crit Care Med</source><year>2014</year><volume>189</volume><fpage>966</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1164/rccm.201309-1592OC</pub-id><?supplied-pmid 24628285?><pub-id pub-id-type="pmid">24628285</pub-id></element-citation><note><p><ext-link ext-link-type="uri" xlink:href="http://f1000.com/prime/718312185">http://f1000.com/prime/718312185</ext-link></p></note></ref><ref id="bib-094"><label>94</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agrawal</surname><given-names>V</given-names></name><name><surname>Smart</surname><given-names>K</given-names></name><name><surname>Jilling</surname><given-names>T</given-names></name><name><surname>Hirsch</surname><given-names>E</given-names></name></person-group><article-title>Surfactant protein (SP)-A suppresses preterm delivery and inflammation via TLR2</article-title><source>PLoS ONE</source><year>2013</year><volume>8</volume><fpage>e63990</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0063990</pub-id><?supplied-pmid 23700442?><pub-id pub-id-type="pmid">23700442</pub-id></element-citation></ref><ref id="bib-095"><label>95</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chambers</surname><given-names>RC</given-names></name></person-group><article-title>Abnormal wound healing responses in pulmonary fibrosis: focus on coagulation signalling</article-title><source>Eur Respir Rev</source><year>2008</year><volume>17</volume><fpage>130</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1183/09059180.00010905</pub-id></element-citation></ref><ref id="bib-096"><label>96</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scotton</surname><given-names>CJ</given-names></name><name><surname>Krupiczojc</surname><given-names>MA</given-names></name><name><surname>K&#246;nigshoff</surname><given-names>M</given-names></name><name><surname>Mercer</surname><given-names>PF</given-names></name><name><surname>Lee</surname><given-names>YC Gary</given-names></name><name><surname>Kaminski</surname><given-names>N</given-names></name><name><surname>Morser</surname><given-names>J</given-names></name><name><surname>Post</surname><given-names>JM</given-names></name><name><surname>Maher</surname><given-names>TM</given-names></name><name><surname>Nicholson</surname><given-names>AG</given-names></name><name><surname>Moffatt</surname><given-names>JD</given-names></name><name><surname>Laurent</surname><given-names>GJ</given-names></name><name><surname>Derian</surname><given-names>CK</given-names></name><name><surname>Eickelberg</surname><given-names>O</given-names></name><name><surname>Chambers</surname><given-names>RC</given-names></name></person-group><article-title>Increased local expression of coagulation factor X contributes to the fibrotic response in human and murine lung injury</article-title><source>J Clin Invest</source><year>2009</year><volume>119</volume><fpage>2550</fpage><lpage>63</lpage><?supplied-pmid 19652365?><pub-id pub-id-type="pmid">19652365</pub-id></element-citation><note><p><ext-link ext-link-type="uri" xlink:href="http://f1000.com/prime/1165077">http://f1000.com/prime/1165077</ext-link></p></note></ref><ref id="bib-097"><label>97</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steinhubl</surname><given-names>SR</given-names></name></person-group><article-title>Platelets as mediators of inflammation</article-title><source>Hematol Oncol Clin North Am</source><year>2007</year><volume>21</volume><fpage>115</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1016/j.hoc.2006.11.015</pub-id><?supplied-pmid 17258122?><pub-id pub-id-type="pmid">17258122</pub-id></element-citation></ref><ref id="bib-098"><label>98</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Navaratnam</surname><given-names>V</given-names></name><name><surname>Fogarty</surname><given-names>AW</given-names></name><name><surname>McKeever</surname><given-names>T</given-names></name><name><surname>Thompson</surname><given-names>N</given-names></name><name><surname>Jenkins</surname><given-names>G</given-names></name><name><surname>Johnson</surname><given-names>SR</given-names></name><name><surname>Dolan</surname><given-names>G</given-names></name><name><surname>Kumaran</surname><given-names>M</given-names></name><name><surname>Pointon</surname><given-names>K</given-names></name><name><surname>Hubbard</surname><given-names>RB</given-names></name></person-group><article-title>Presence of a prothrombotic state in people with idiopathic pulmonary fibrosis: a population-based case-control study</article-title><source>Thorax</source><year>2014</year><volume>69</volume><fpage>207</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1136/thoraxjnl-2013-203740</pub-id><?supplied-pmid 24002055?><pub-id pub-id-type="pmid">24002055</pub-id></element-citation><note><p><ext-link ext-link-type="uri" xlink:href="http://f1000.com/prime/718098688">http://f1000.com/prime/718098688</ext-link></p></note></ref><ref id="bib-099"><label>99</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noth</surname><given-names>I</given-names></name><name><surname>Anstrom</surname><given-names>KJ</given-names></name><name><surname>Calvert</surname><given-names>SB</given-names></name><name><surname>Andrade</surname><given-names>J de</given-names></name><name><surname>Flaherty</surname><given-names>KR</given-names></name><name><surname>Glazer</surname><given-names>C</given-names></name><name><surname>Kaner</surname><given-names>RJ</given-names></name><name><surname>Olman</surname><given-names>MA</given-names></name></person-group><article-title>A placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosis</article-title><source>Am J Respir Crit Care Med</source><year>2012</year><volume>186</volume><fpage>88</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1164/rccm.201202-0314OC</pub-id><?supplied-pmid 22561965?><pub-id pub-id-type="pmid">22561965</pub-id></element-citation><note><p><ext-link ext-link-type="uri" xlink:href="http://f1000.com/prime/717951800">http://f1000.com/prime/717951800</ext-link></p></note></ref><ref id="bib-100"><label>100</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leslie</surname><given-names>KO</given-names></name></person-group><article-title>Idiopathic pulmonary fibrosis may be a disease of recurrent, tractional injury to the periphery of the aging lung: a unifying hypothesis regarding etiology and pathogenesis</article-title><source>Arch Pathol Lab Med</source><year>2012</year><volume>136</volume><fpage>591</fpage><lpage>600</lpage><pub-id pub-id-type="doi">10.5858/arpa.2011-0511-OA</pub-id><?supplied-pmid 22136526?><pub-id pub-id-type="pmid">22136526</pub-id></element-citation><note><p><ext-link ext-link-type="uri" xlink:href="http://f1000.com/prime/718489791">http://f1000.com/prime/718489791</ext-link></p></note></ref><ref id="bib-101"><label>101</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cool</surname><given-names>CD</given-names></name><name><surname>Groshong</surname><given-names>SD</given-names></name><name><surname>Rai</surname><given-names>PR</given-names></name><name><surname>Henson</surname><given-names>PM</given-names></name><name><surname>Stewart</surname><given-names>JS</given-names></name><name><surname>Brown</surname><given-names>KK</given-names></name></person-group><article-title>Fibroblast foci are not discrete sites of lung injury or repair: the fibroblast reticulum</article-title><source>Am J Respir Crit Care Med</source><year>2006</year><volume>174</volume><fpage>654</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1164/rccm.200602-205OC</pub-id><?supplied-pmid 16799077?><pub-id pub-id-type="pmid">16799077</pub-id></element-citation><note><p><ext-link ext-link-type="uri" xlink:href="http://f1000.com/prime/30414">http://f1000.com/prime/30414</ext-link></p></note></ref><ref id="bib-102"><label>102</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galvin</surname><given-names>JR</given-names></name><name><surname>Frazier</surname><given-names>AA</given-names></name><name><surname>Franks</surname><given-names>TJ</given-names></name></person-group><article-title>Collaborative radiologic and histopathologic assessment of fibrotic lung disease</article-title><source>Radiology</source><year>2010</year><volume>255</volume><fpage>692</fpage><lpage>706</lpage><pub-id pub-id-type="doi">10.1148/radiol.10090717</pub-id><?supplied-pmid 20501710?><pub-id pub-id-type="pmid">20501710</pub-id></element-citation></ref><ref id="bib-103"><label>103</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dail</surname><given-names>DH</given-names></name></person-group><article-title>Pulmonary apical cap</article-title><source>Am J Surg Pathol</source><year>2001</year><volume>25</volume><fpage>1344</fpage><pub-id pub-id-type="doi">10.1097/00000478-200110000-00024</pub-id><?supplied-pmid 11688475?><pub-id pub-id-type="pmid">11688475</pub-id></element-citation></ref><ref id="bib-104"><label>104</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carloni</surname><given-names>A</given-names></name><name><surname>Poletti</surname><given-names>V</given-names></name><name><surname>Fermo</surname><given-names>L</given-names></name><name><surname>Bellomo</surname><given-names>N</given-names></name><name><surname>Chilosi</surname><given-names>M</given-names></name></person-group><article-title>Heterogeneous distribution of mechanical stress in human lung: a mathematical approach to evaluate abnormal remodeling in IPF</article-title><source>J Theor Biol</source><year>2013</year><volume>332</volume><fpage>136</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1016/j.jtbi.2013.04.038</pub-id><?supplied-pmid 23665208?><pub-id pub-id-type="pmid">23665208</pub-id></element-citation><note><p><ext-link ext-link-type="uri" xlink:href="http://f1000.com/prime/718009926">http://f1000.com/prime/718009926</ext-link></p></note></ref><ref id="bib-105"><label>105</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wiggins</surname><given-names>J</given-names></name><name><surname>Strickland</surname><given-names>B</given-names></name><name><surname>Turner-Warwick</surname><given-names>M</given-names></name></person-group><article-title>Combined cryptogenic fibrosing alveolitis and emphysema: the value of high resolution computed tomography in assessment</article-title><source>Respir Med</source><year>1990</year><volume>84</volume><fpage>365</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/S0954-6111(08)80070-4</pub-id><?supplied-pmid 2247666?><pub-id pub-id-type="pmid">2247666</pub-id></element-citation></ref><ref id="bib-106"><label>106</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cottin</surname><given-names>V</given-names></name><name><surname>Cordier</surname><given-names>J</given-names></name></person-group><article-title>The syndrome of combined pulmonary fibrosis and emphysema</article-title><source>Chest</source><year>2009</year><volume>136</volume><fpage>1</fpage><lpage>2</lpage><pub-id pub-id-type="doi">10.1378/chest.09-0538</pub-id><?supplied-pmid 19584202?><pub-id pub-id-type="pmid">19584202</pub-id></element-citation></ref></ref-list><glossary><title>Abbreviations</title><def-list id="dl1"><def-item><term>BAL</term><def><p>bronchoalveolar lavage</p></def></def-item><def-item><term>COPD</term><def><p>chronic obstructive pulmonary disease</p></def></def-item><def-item><term>CCL</term><def><p>chemokine (C-C motif) ligand</p></def></def-item><def-item><term>CXCL</term><def><p>C-X-C motif chemokine</p></def></def-item><def-item><term>ER</term><def><p>endoplasmic reticulum</p></def></def-item><def-item><term>FIP</term><def><p>familial interstitial pneumonia</p></def></def-item><def-item><term>HP</term><def><p>hypersensitivity pneumonitis</p></def></def-item><def-item><term>HPS</term><def><p>Hermansky-Pudlak syndrome</p></def></def-item><def-item><term>ILD</term><def><p>interstitial lung disease</p></def></def-item><def-item><term>IPF</term><def><p>idiopathic pulmonary fibrosis</p></def></def-item><def-item><term>MMP</term><def><p>matrix metalloprotease</p></def></def-item><def-item><term>SNP</term><def><p>single-nucleotide polymorphism</p></def></def-item><def-item><term>TLR</term><def><p>Toll-like receptor</p></def></def-item><def-item><term>UIP</term><def><p>usual interstitial pneumonia</p></def></def-item></def-list></glossary></back></article>